The Stability of Monoclonal Antibodies by Heron, Andrew David
The Stability of Monoclonal 
Antibodies
Andrew David Heron
Thesis presented for the degree of Doctor of Philosophy
Department of Chemistry
University of Glasgow
October, 1999
v : * '  > * .■  ■■
© Andrew David Heron, 1999
ProQuest Number: 13834088
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 13834088
Published by ProQuest LLC(2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
g m s g o w
U'-'JVERSITYLmgABY
i/fci
Acknowledgements
I would like to thank my supervisors Alan Cooper and Ulla Lashmar for their help 
and guidance over the past three years. I must also thank Nick Price and Sharon Kelly at the 
University of Stirling for their circular dichroism work, without which the data presented in 
this thesis would not have been possible. Thanks to Sarah Barron, Lindsay McDermott, 
Margaret Nutley, Samantha Rutherford and Tennie Videler for their help, interest, friendship 
and laughs. Many thanks also to Glaxo Wellcome for generously funding my three years of 
research. And finally, to mum and Janey, thank you for your constant support, 
encouragement and of course patience.
Abstract
The Stability of Monoclonal Antibodies
Monoclonal antibodies (mAbs) are antibodies which are homogeneous and are of 
constant specificity and affinity. These properties make them ideal targets for rational drug 
design as molecular biology techniques allows the therapy to be genetically designed to fit the 
disease or condition, but, the inherent instability and aggregation propensity of such protein 
drugs poses serious problems for the pharmaceutical industry. With these problems in mind, 
the stability of mAbs in solution has been extensively studied using a range of biophysical 
techniques. With a view to correlating thermal unfolding data with protein drug shelf-life, 
differential scanning calorimetry (DSC) was used to study the thermal unfolding of three 
mAbs (Campath-IH, 4162W94 and 1209W95). It was found that each of the antibodies 
unfolds irreversibly and, by complementing DSC results with results from circular dichroism 
(CD) and intrinsic tryptophan fluorescence spectroscopy, we show all three mAbs unfold by 
firstly undergoing a small change in tertiary structure which is then followed by, at a higher 
temperature, major changes in both tertiary and secondary structure after which all structure 
is lost. Kinetic analysis of these irreversible processes over a range of pH and DSC scan 
rates resulted in the calculation of the activation energy (E a) and rate constants of unfolding. 
Extrapolation of these rate constants to physiological conditions afforded an estimate of drug 
shelf-life which we have shown is relevant only when thermal unfolding is the only reaction 
resulting in protein denaturation. The effect of various additives on the thermal unfolding of 
the antibodies has also been studied using both DSC and fluorescence spectroscopy, in 
particular fluorescence quenching techniques and the use of the extrinsic fluorescent probe 
ANS (8-anilino-l-naphthalene sulfonic acid). These studies revealed that mannitol exerts a 
strong stabilising influence i.e. increases the mean unfolding temperature (Tm) whereas 
cyclodextrins decrease the Tm and are therefore considered destabilising additives. 
Cyclodextrins also prevent gross thermal aggregation of the mAbs possibly as a result of 
binding to exposed hydrophobic amino acid residues and masking hydrophobic patches which 
are indicated in aggregate formation.
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1.1 Aims of Thesis
The aim of this project has been the extensive investigation of a wide range of factors 
affecting the stability of monoclonal antibodies (mAbs), as part of a general approach to 
formulation development of these molecules, using a range of biophysical techniques. The 
techniques used include fluorescence spectroscopy, circular dichroism and differential 
scanning calorimetry (DSC). The broad objectives were:
1. To determine the thermal stability characteristics of mAbs in solution under various 
conditions using sensitive DSC and related calorimetric techniques.
2. To compare the effects of pH, adjuvants and other additives on the reversibility of thermal 
denaturation and related coagulation/aggregation phenomena.
3. To study the dynamic accessibility of protein groups using fluorescence quenching and 
related spectroscopic techniques, in comparison with stability studies under similar conditions.
4. To relate calorimetric and dynamic parameters to long-term storage properties of these 
proteins.
5. To apply these biophysical techniques to appropriately aged samples to examine possible 
diagnostic/analytical/quality control applications.
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1.2 Introduction
Antibodies (also referred to as immunoglobulins, Ig) are produced by an individual’s 
immune response to a foreign substance or invading pathogen (antigen), and perform a crucial 
role in the individual’s immune defence. Nature has designed these molecules to be 
bifunctional in that they bind their antigen with exquisite specificity and selectivity but their 
function is also to activate the wide range of effector functions which will ultimately lead to 
the inactivation and removal of the antigen. This bifunctionality is essential for the immune 
system of the host to function effectively but it has also meant that antibodies have become 
indispensable tools in the laboratory whether it be in experimental research, clinical 
investigation or diagnosis, or most recently as therapeutic agents.
The role of antibodies in the host immune response requires the host to produce a 
wide range of antibody molecules from a range of antibody producing cells to recognise and 
bind the array of antigenic determinants (epitopes) present on the surface of invading 
pathogens. These antibodies are known as polyclonal antibodies. However, the role of 
antibodies as laboratory reagents or therapeutic drugs usually requires them to recognise only 
one molecule or even a single epitope and such antibodies are known as monoclonal 
antibodies (mAbs). This thesis is concerned with investigations into the stability of mAbs 
which have been developed and produced as therapeutic agents.
1.3 Summary of the Immune Response
The human immune response is a vastly complex system on which many textbooks 
and literature can be found. This thesis is not concerned with the production of antibodies in 
vivo but rather the finished product of production in vitro, but to set the work in context, a 
summary of the immune response, much simplified, follows.
To invoke an immune response, a foreign substance or invading pathogen must be 
recognised by antigen-specific lymphocytes of which there are two types: B lymphocytes (B 
cells) and T lymphocytes (T cells). Activation of these lymphocytes can occur when antigen 
binds to the lymphocyte surface via specific cell surface receptors. In the case of B cells these 
receptors are membrane-bound antibody molecules. T cell activation results in the destruction
3
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and removal of infected host cells whereas B cell activation results in two main events; firstly 
the activated B cell divides and multiplies producing a ‘clone’ of identical cells then secondly 
these clones differentiate into either plasma cells or memory B cells. Plasma cells are able to 
secrete large amount of soluble antibody of the same specificity as the original membrane- 
bound antibody which bound the original antigen whereas the function of memory B cells is to 
produce an enhanced immune response on subsequent re-exposure to the same antigen. 
Activation of memory B cells leads to the production of antibodies with a higher affinity for 
antigen than those produced by the primary immune response.
1.4 Structure of Antibodies
As a rule, antibody molecules are glycoproteins whose basic unit comprises two 
identical glycosylated heavy chains of relative molecular mass 50 000-75 000 and two 
identical, nonglycosylated light chains of molecular mass 25 000 (Figure 1.1) (Goding, 1996). 
These chains are arranged in a symmetrical fashion, the heavy chains joined by disulfide 
bonds to each other and each light chain joined to a heavy chain by a disulfide bond. This 
disulfide bonding arrangement characteristic of immunoglobulins although the exact number 
and the locations of the bonds is variable (Nisonoff, et al., 1975).
Each chain of the antibody molecule is composed of domains: heavy chains contain 
either four or five depending on their class (IgG, IgA and IgD contain four; IgM and IgE 
contain five) and light chains contain two domains.(The grouping of immunoglobulins into 
five main classes is a somewhat complex affair where the class depends on the heavy chain of 
the molecule. IgM, IgD, IgG, IgE and IgA possess p., 8, y, e and a  heavy chains respectively. 
Individual classes have distinctive structures and biological functions.) Further subgrouping 
of individual Ig classes occurs as although IgM and IgD have single genes, the remaining 
classes often do not and are subdivided into subclasses (for example, there are four subclasses 
of IgG in mouse rat and human (designated IgGl, IgG2, etc.) but only one in the rabbit), each 
with its own constant region gene. There are also two types of light chain (k  and X), a fact 
which is used in this complex classification system. An expert and readable guide to this 
classification minefield is given in Goding, 1996.
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Antibody binding site 
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receptors (or CH2)
COOH COOH
Figure 1.1: Basic structure of an antibody molecule (From Ritter and Ladyman, 1995)
Chapter I
The ability of the antibody to bind antigen is controlled by the N-terminal domains. 
Each antigen binding site is created by the combination of one domain from the heavy chain 
and one from the light chain with the remaining domains of the molecule required for the 
effector functions of the molecule. The N-terminal domains of the molecule are termed 
variable domains (V domains) as their primary structures vary considerably between 
antibodies of differing specificity whereas the primary structure of the other domains in the 
molecule is relatively constant and these are known as constant domains (C domains). Due to 
the symmetry of the molecule (the two heavy chains are identical and so are the two light 
chains), each antibody molecule contains two identical sites for antigen binding.
Despite the N-terminal domains of the molecule being labelled ‘variable’, the 
variability in primary structure is not spread throughout the domain but in fact it is focused in 
three main areas which are designated the hypervariable regions or complementarity 
determining regions (CDR). Changes in the amino acid sequence in these regions of the 
molecule alter the molecules specificity and affinity for antigen by changing the shape of the 
binding site and also altering potential interactions between antigen and antibody.
As mentioned previously, the general structure of Igs is a Y-shaped molecule 
composed of two heavy (H) chains and two light (L) chains. Within this structure there are 
well-defined domains: the L chain consists of VL and CL domains and the H chains comprise 
the VH, CHi, Ch2, and Ch3 domains. Each of these domains consist of approximately 100 
residues, are homologous in their primary structures, and are independent, stable structural 
units. On a secondary structural level, each domain is a compact, globular structure 
containing large amount of p-sheet. This motif has been termed the immunoglobulin fold 
(Poljak, et al., 1973) and consists of two layers of antiparallel P-sheets that are usually linked 
by a disulfide bond (fig. 1.2). Individual domains are rather resistant to proteolytic attack 
(Goding, 1996) in contrast to the short linking sequences joining individual domains. Some 
classes of antibody also contain an extra hinge region between the Chi and Ch2 domains. This 
region tends to have a more open and flexible structure and in hence is especially susceptible 
to proteolysis. The biological function of this hinge region, if any, is probably to allow the 
antibody to bind polymeric antigens which have a varying distance between epitopes. Recent 
work in solving the structure of an IgG molecule including the hinge region has revealed the
6
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conformation of this region (Harris, et al., 1992). A cartoon of the crystal structure of an IgG 
molecule is given in figure 1.3.
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Figure 1.2: The immunoglobulin fold. This fold comprises two layers of antiparallel (3-sheet 
folded on top of each other to form a sandwich-like structure. Located between the two layers 
are hydrophobic residues and the indicated disulfide bond linking two cysteine residues which 
are about 60 residues apart. The VL domain is illustrated here and the loops containing the 
hypervariable regions are shaded dark. (From Creighton, 1993)
Chapter 1
Figure 1.3: Cartoon illustrating the structure o f the IgG molecule. The heavy chains are 
coloured orange and the light chains coloured green. The purple region represents the 
carbohydrate attached to the heavy chains. The antigen binding regions are labelled Fab and 
the constant region is labelled Fc.
Q
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1.5 What Are Monoclonal Antibodies?
When an antigen provokes an immune response it does so by being recognised by B 
cells though each B cell which recognises the antigen may bind a different epitope with a 
different affinity. This diversity of recognition will be carried through to the antibodies which 
are secreted in the plasma after clonal expansion and differentiation and since many B cells 
will have undergone clonal expansion, these antibodies will be the product of many clones and 
are therefore referred to as polyclonal. In polyclonal antibodies, nature has produced a highly 
effective ‘army’ to fight invading pathogens, both in terms of sheer quantity of antigen- 
antibody binding but also in the range of effector functions that can be activated. These 
properties are not usually required for laboratory reagents though, rather a homogeneous 
species of constant specificity and affinity which therefore has predictable behaviour is 
desired. Such a reagent are monoclonal antibodies.
The development of a technique to produce monoclonal antibodies is credited to 
Gorges Kohler and Cesar Milstein as part of their research into the mechanisms underlying 
the diversity of antibodies (Kohler and Milstein, 1975). To obtain a monoclonal antibody, it 
is necessary to isolate and propagate single antibody-secreting B cell clones. This is not 
directly possible but by combining the nuclei of normal antibody-secreting cells with those of 
their malignant counterparts, Kohler and Milstein were successful and for their achievements 
were awarded the Nobel Prize in Physiology and Medicine in 1984.
Put very simply, the essence of the technique involves the selection of a B cell which 
can produce one specific antibody (but has a lifetime of only a few days in culture) and fusing 
it with a myeloma cell which although it is no longer viable as an antibody-producing cell, has 
the property of immortality in culture. The fusion product is a hybridoma cell which is 
immortal due to mitotic cell division which results in an ever expanding clone of identical 
cells. A more detailed description of this procedure in contained in Ritter and Ladyman, 
1995.
Although this work was the result of basic research into the mechanism of generation 
of antibody diversity it had revolutionary consequences for biological research and clinical
10
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medicine and resulted in the generation of an industry. It also laid the foundation for other 
techniques common today, for example the molecular methods which result in the production 
of ‘designer’ mAbs after manipulation of the genes encoding the heavy and light chains of the 
molecule. Such gene manipulation allows for the design and production of humanized mAbs 
which comprise CDRs of rodent origin genetically grafted into a human mAb framework. 
This process allows these mAbs to be used in vivo without producing an anti-rodent immune 
response (and subsequent production of human anti-mouse antibody, HAMA) in the patient. 
Although simple in theory, this approach to mAb production has many pitfalls including a 
reduction in the final antibody affinity and the technique is very labour intensive and requires 
specialist expertise in genetic engineering (Borrebaeck, 1992). Despite these drawbacks, the 
technique remains popular within the pharmaceutical industry as a means of producing mAbs 
as novel clinical agents. mAbs as clinical agents can be broadly divided into two types: firstly 
an agent which depends on the antibody binding a specific antigen which is indicated in a 
particular disease state and secondly the antibody as an agent conjugated to another drug. 
The former are normally used in the treatment of conditions of the immune system, for 
example rheumatoid arthritis (Choy, 1998) with the latter being more commonly used as a 
treatment for cancers (Trail, et al., 1997; Panchal, 1998; Farah, et al., 1998). The three 
antibodies studied and described within this thesis (Campath-IH, 4162W94 and 1209W95) 
are all humanized mAbs developed by Glaxo Wellcome and a brief description of each of 
these pharmaceuticals and their mechanism of action follows.
1.4.1 Campath-IH
Campath-1 is the generic name given to a series of rat mAbs produced by Waldmann, 
et al for the lysis of normal and malignant cells (Hale, et al., 1983). These antibodies 
recognise the CD52 antigen (also known as the Campath-1 antigen) which is a small 
glycosylphosphatidylinositol (GPI) anchored glycopeptide which is abundantly expressed on 
virtually all human lymphocytes (Hale, et al., 1993; Xia, et al., 1993). This antigen 
comprises a twelve amino acid sequence (Treumann, et al., 1995; Rowan, et al., 1998) and 
has recently had its structure, when bound to Campath-IH, solved (Cheetham, et al., 1998).
The unique ability of the Campath-IH antibodies (IgGl class) to kill lymphocytes by 
both complement- and cell-mediated lysis led to their extensive development as therapeutic 
agents. The rat mAb, Campath-1G, was the first agent to be effective therapy in vivo but as
11
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it was of rodent origin there was a high possibility that it would elicit an anti-globulin 
response. To combat this and to produce a therapy which would be more effective in patients, 
Campath-IH was produced by Riechmann, et al., (1988) using a pioneering humanization 
technique. This technique involved combining only the CDRs from the original rat mAb and 
the human IgG framework to produce a humanized mAb which did not elicit an anti-globulin 
response but retained highly specific and tight binding in addition to providing native human 
effector functions.
So promising were the preliminary results of clinical trials of Campath-IH, that 
expression systems were developed in order to produce it in suitable quantities for large scale 
clinical trials (Page, et al., 1991; Carroll, et al., 1992; Crowe, et al., 1992). Campath-IH has 
been indicated in the treatment of non-Hodgkin lymphoma (NHL) (Lim, et al., 1993) and 
rheumatoid arthritis (Isaacs, et al., 1992; Weinblatt, et al., 1995). At the time of writing it 
had recently been approved by the Federal Drugs Administration (FDA) as a therapy for 
NHL.
Work carried out on the formulation development of Campath-IH identified an acid 
labile Asp-Pro bond at residues 274-275 in the heavy chain of the molecule (Wellcome 
Company Document No: BZGA/91/0018, 1992, private communication) and N-terminal 
sequencing suggested this acid lability is a general feature which is not unique to Campath-IH 
but can also be observed in other IgGs. In the case of Campath-IH though, the cleavage 
could be avoided by minimising exposure to extreme conditions of acid pH and high 
temperature. Development studies also highlighted another cleavage site within the molecule, 
this time within the hinge region. The labile Lys226-Thr227 bond was found to undergo 
cleavage in the presence of divalent copper ions- a direct effect of the copper ions interacting 
with amino acid residues within the proximity of this bond (Wellcome Company Document 
No: BZGA/91/0011, 1991, private communication). These findings, in addition to results 
from other studies resulted in Campath-IH being formulated as a solution of mAb (10 mg/ml) 
in pH 7.2 0.01 M phosphate buffered saline, 2 mM EDTA (a chelating agent to bind Cu2+ and 
therefore minimise copper-induced cleavage reactions) with the recommendation that the 
product be stored at 4 °C out of direct light.
12
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1.4.2 4162W94
4162W94 is the Glaxo Wellcome company name for an investigational drug being 
studied as immunotherapy for rheumatoid arthritis. Like Campath-IH it is a humanized mAb 
(IgGl class) but it recognises the CD4 (cluster differentiation 4) antigen (unlike Campath-IH 
which has the CD52 molecule as its antigen). CD4 molecules are found on the surface of T 
cells, which, as described in section 1.2, are molecules crucially involved in the human 
immune response. It is the T cells that are involved in the initiation and maintenance of auto­
immune diseases such as rheumatoid arthritis and therefore to treat these diseases effectively 
it would be desirable to find a means of controlling these T cells without compromising the 
rest of the immune system.
4162W94 targets the CD4 molecules and on binding, induces a state of 
unresponsiveness, or anergy, in the T cells. The ability of the mAb to transiently block the 
function of the T cells without killing them and render them permanently anergic, while at the 
same time leaving the rest of the immune response able to respond normally to pathogens, 
makes it a logical target as a therapy for rheumatoid arthritis.
Formulation studies at the time of development resulted in 4162W94 being 
formulated as a 10 mg/ml solution in 50 mM citrate buffer, pH 6.0, 0.05 mM EDTA and 
0.01% (w/w) polysorbate 80 (Wellcome Company Document, Investigator’s Brochure- 
4162W94, private communication). EDTA was included in the formulation to minimise 
cleavage at the Cu2+ dependent cleavage site identified in the structure of Campath-IH as 
4162W94 shares the same IgG framework. The purpose of the polysorbate 80 was to 
stabilise the mAb by preventing/reducing the formation of insoluble aggregates.
1.4.3 1209W95
Again 1209W95 is a humanized monoclonal antibody (IgG4 class) in development by 
Glaxo Wellcome as a therapeutic agent. This molecule differs from both Campath-IH and 
4162W94 not only in its IgG class but also in the fact that it has been designed as an 
antibody-bromo-acetyl TMT (terpyridine methylene tetraacid- a metal chelator)-antibody 
conjugate. TMT allows the chelation of the therapeutic isotopes Y ttrium  and 177Lutetium 
and, by recognising a 40 kD tumour antigen, directs these radiotherapeutic agents to the
13
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tumour site without causing extensive healthy tissue damage. This mAb is relevant as an 
oncology therapy in the treatment of advanced prostate and lung cancer.
Work on the development of this molecule has shown it to be ‘considerably less 
stable’ than both Campath-IH and 4162W94 (Wellcome Company Document No: 
DPPP/95/0009, 1995, private communication). Not only is the mAb sensitive to acid pH 
(below pH 5.5 TMT is cleaved from the molecule) but considerable precipitation is observed 
by agitation or bubbling with air or nitrogen to the extent that continuous overnight shaking 
removes 98% of the soluble antibody (Wellcome Company Document No: DPPP/95/0009, 
1995, private communication). This inherent propensity to precipitate, which is not a concern 
with Campath-IH and 4162W94, may be due to the mutations carried out within the IgG 
framework to allow the site-specific conjugation of the TMT.
To maximise the stability of the molecule in solution, the antibody is formulated as a 
15 mg/ml solution in 100 mM tris/HCl buffer, pH 8.0, 0.05 mM EDTA and 0.01% (w/w) 
polysorbate 80 (Wellcome Company Document No: DPPP/95/0009, 1995, private 
communication). The additives in this formulation perform the same function as they do in 
the formulation of 4162W94 i.e. EDTA chelates divalent metal ions and minimises their 
interaction with the mAb and the polysorbate 80 reduces the formation of insoluble 
precipitates.
1.5 Stability of Monoclonal Antibodies
It is widely recognised that, as a class of protein pharmaceuticals, mAbs require 
sensitive handling and storage and, from production through to final formulation, techniques 
sympathetic to the nature of the proteins must be employed. Despite this recognition, 
surprisingly little literature is available on the effects of various reagents and techniques on 
mAbs, a fact which is a little less surprising when one bears in mind that the production of 
therapeutic mAbs is carried out almost exclusively by the pharmaceutical industry who are 
notoriously reluctant to divulge the results of their research.
The influence and effects of the production and storage of mAbs on their specificites, 
as measured by functional assays, has been studied although the mAbs discussed were not
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clinical agents but laboratory reagents (Underwood and Bean, 1985). The effects of pH, 
hydrogen peroxide and temperature on a therapeutic mAb as measured by physical techniques 
(turbidity measurements, chromatographic techniques and matrix-assisted laser desorption 
ionization time-of-flight mass spectrometry (MALDI TOF MS)) has also been the subject of 
published reports (Usami, et al., 1996). Gombotz, et al., (1994), studied the effects of 
another formulation additive, poly(vinylpyrrolidone), on the stabilization of a therapeutic mAb 
using a range of techniques including differential scanning calorimetry (DSC) and a functional 
assay. The use of fluorescence spectroscopic techniques to monitor conformational changes 
relevant to the stability of mAbs in addition to the use of functional assays has also been 
reported (Jiskoot, et al., 1990).
The determination of the optimal storage conditions for mAbs, and indeed all protein 
pharmaceuticals, requires sensitive and reliable assays with which the stability of the mAb to 
various treatments and additives can be determined. Traditional methods e.g. enzyme-linked 
immunosorbent assay (ELISA) and even modem surface plasmon resonance (SPR) techniques 
are used to quantify bioactivity which is the most critical assay of stability but these 
techniques fail to give any information on the mechanism(s) of inactivation. Such functional 
assays, especially ELISA can be complex techniques which can be less reproducible than 
simpler physical techniques. A comparison of the storage stability of a solution of a 
therapeutic mAb as determined by DSC and two functional assays (ELISA and an affinity 
chromatographic technique) has been reported (Brouillette, et al., 1996) and concluded that 
DSC is useful as an ‘aid’ to protein pharmaceutical formulation.
1.6 DSC and Pharmaceuticals
As mentioned in the preceding section, DSC has been shown to be an aid to protein 
pharmaceutical development. The maintenance of the native tertiary structure of a protein is 
required for bioactivity and hence a measure of native structure can be used to determine 
stability; many modifications of proteins (both chemical and physical) which lead to loss of 
bioactivity can be detected and quantified by analysing the equilibrium between the folded and 
unfolded states of the protein as a function of some additive (usually a chaotropic agent e.g. 
urea) or temperature (Brouilette, et al., 1996). DSC is a technique which lends itself to such 
an analysis and not only does it provide information on the thermodynamic stability of the
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native conformation but it also can be used to quantify the amount of native protein present 
(Brouilette, et al., 1996).
DSC has proven its value in the field of physical pharmacy but almost exclusively as 
a tool for analysing the reactions of traditional organic drugs whether it be in solid form or in 
solution. DSC has been used for studies of the wetting and stability of such compounds and 
excellent reviews of this area have been published (Buckton and Beezer, 1991; Koenigbauer, 
1994). When used to analyse protein pharmaceuticals, DSC is normally used as a means of 
conveniently studying the effects of various additives on the protein (Ahmad and Bigelow, 
1986; Chang et al., 1993; Gombotz et al., 1994; Pico, 1996; Fatouros et al., 1997a; 1997b; 
Giancola et al., 1997; Remmele et al., 1998) by observing any changes in the Tm of unfolding, 
that is the peak maximum of the denaturation endotherm. Such observations are made on the 
basis that an additive expected to stabilise protein should increase the Tm while a destabilizing 
additive should decrease the Tm. One of the goals of this thesis is to investigate whether the 
role of DSC in the formulation of protein pharmaceuticals can be taken further than this 
rather empirical level.
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MATERIALS AND METHODS
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2.1. Reagents Used
Buffer Reagents
Sodium acetate (anhydrous), sodium dihydrogen orthophosphate dihydrate, potassium 
chloride and ethylenediamine tetraacetic acid (EDTA) were purchased from BDH Laboratory 
Supplies, Poole, England. Sodium chloride, citric acid and trisodium citrate were purchased 
form Fisher Scientific UK Ltd, Loughborough, England. Acetic acid (99.8%) was purchased 
from Riedel-de Haen, Seelze-Hannover.
Formulation Additives
Pluronic F-68 (Poloxamer 188, Product No.: P 1300), lactitol (4-0-p-D-galactopyranosyl-D- 
glucitol, Product No.: L 3520), DEAE-dextran (chloride form, Product No.: D9885), L- 
histidine (Product No.: H 8000) were all purchased from Sigma Chemical Co. N- 
methylacetamide, hydroxy propyl- P-cyclodextrin (average molar substitution = 0.6, Cat. No.: 
33,261-5), methyl-P-cyclodextrin (average molar substitution = 1.8, Cat. No.: 33,261-5) were 
purchased from Aldrich Chemical Co. Mannitol was purchased from BDH Laboratory 
Supplies.
Fluorescence Spectroscopy Reagents
Succinimide (Product No.: S 9381) and acrylamide (>99%, electrophoresis reagent, Product 
No.: A 8887) and L-tryptophan (Product No.: T 8659) were purchased from Sigma Chemical 
Co. ANS (8-anilino-l-naphthalene-sulphonic acid, Cat. No.: 13,992-0) was purchased from 
Aldrich Chemical Co. Succinimide was recrystallised from ethanol prior to use.
Circular Dichroism Reagents
Urea (ultrapure grade, Product No.: U-0631) was purchased from Sigma Chemical Co. 
Guanidine Hydrochloride (ultrapure grade) was purchased from Life Technologies Inc., 
Paisley, Scotland and the absolute concentrations checked by refractive index measurements 
(Nozaki, 1972) by Dr Sharon Kelly, University of Stirling.
SDS-PAGE Reagents and Solutions
Coomassie Blue Destain: 25% methanol, 10% acetic acid and 1% glycerol.
Coomassie Blue Stain'. 0.1% Coomassie Blue R-250 (Sigma Chemical Co.) in destain.
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Running Buffer. 1440 g glycine (Sigma Chemical Co.), 300 g Tris-base (Sigma Chemical 
Co.), 50 g SDS (Schwarz/Mann Biotech.) per 10 L.
Sample Buffer: 5 g SDS, 5 ml Tris (1 M, pH 7.5), 100 mM PMSF (phenylmethylsulfonyl 
fluoride) (Sigma Chemical Co.) in isopropanol, 100 mM EDTA, 10 ml glycerol, 2% 
bromophenol blue (BDH) made up to 100 ml with distilled H2Q to pH 6.8.
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2.2 Differential Scanning Calorimetry
2.2.1 Thermal Stability Studies
The bulk of the stability studies described in this thesis were carried out using the 
MicroCal MC-2 differential scanning calorimeter fitted with an EM Electronics N2a DC 
nanovoltmeter. In the latter stages of the project a MicroCal MCS system and a VP-DSC 
system were also used. All three instruments are PC operated which is also used for data 
collection. With the exception of experiments to determine kinetic parameters, a nominal scan 
rate of 60 °C/hr and a “filter” setting of 15 s were applied (the filter setting refers to data 
acquisition and averaging time e.g. a filter setting of 15 s will record and store averaged 
energy and temperature data every 15s).
Sample solutions were prepared by exhaustive dialysis of mAb solutions against the 
required buffer with the relevant additive then added to both dialysed solution and dialysis 
buffer to the same exact concentration where necessary. Protein concentrations were typically 
2-3 mg/ml for the MC-2 and MCS instruments, 0.5-1 mg/ml for the VP-DSC system. The 
dialysis buffer was used for reference and baseline scans. Both sample and buffer solutions 
were degassed before loading into the calorimeter cells (to avoid bubble formation at higher 
temperatures) by placing the solution under vacuum for two or three minutes using a small 
desiccator attached to a water aspirator, mounted on a magnetic stirrer.
Both cells of the calorimeter were rinsed thoroughly with buffer prior to filling. 
Filling of the cells was achieved using a small syringe fitted with a length of narrow gauge 
Teflon tubing (filling of the VP-DSC cells was achieved using a glass Hamilton syringe and a 
Teflon filling funnel as supplied by the manufacturer). It is vital that there are no air bubbles 
either in the cells or in the inlet tube and therefore extreme care was taken to make sure the 
syringe and tubing were bubble-free. To prevent the cell contents boiling and to suppress 
bubble formation during DSC, a pressure head of 1-2 atm of nitrogen was maintained (this is 
unnecessary when using the VP-DSC system as it has a self-pressurising sample chamber). 
One or more buffer baseline scans were obtained by filling both the reference and sample cells 
with the appropriate buffer and scanning in the normal manner, as described in the 
manufacturers instructions.
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The protein sample solution was then loaded into the sample cell. The small amount 
of buffer left in the sample cell prior to filling leads to a slight dilution of the sample, however 
this is avoided by rinsing the cell with a small quantity of the sample and then discarding. A 
little of the sample was retained for protein concentration determination using UV/visible 
spectrophotometry.
2.2.2 DSC Data Analysis
DSC data were analysed using MicroCal Origin software packages (versions 2.90, 
4.1 and 5.0 for the MicroCal MC-2, MCS and VP-DSC systems respectively). The software 
collects differential thermal energy data as a function of time i.e. a typical data file will 
consist of the time, cell temperature and differential energy input into the cells since the last 
data point, at intervals determined by the filter setting. Conversion to differential heat 
capacity requires division by the mean scan rate at each point.
Due to variations in the total heat capacity and heat losses in the instrument, the DSC 
scan rate can vary over the programmed temperature range. This effect results in a curvature 
of the DSC trace. Most of the artefacts and nonlinearities arising from instrumental problems 
such as mismatch of cell volume are eliminated by subtracting a buffer baseline.
It is common practise for the differential heat capacity to be normalized to differential 
heat capacity per mole of sample by dividing by the total amount of sample in the cell (i.e. 
conversion of cal/°C to cal/mol/°C). Origin software performs this function and has the cell 
volumes set as a default and a text box to allow entry of the sample concentration. A non-two 
state model, based on original work by Sturtevant, Brandts and Privalov (Sturtevant, 1974, 
1987; Jackson and Brandts, 1970; Privalov and Potekhin, 1986) was fitted to these 
normalized experimental data using the facility built into the software package. The model 
used is based upon the van’t Hoff equation:
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where AHvH is the van’t Hoff heat change for the reaction which corresponds to the heat 
change for the cooperative unit which actually participates in the reaction.
Normally it is understood that the protein is composed of a number of structural 
domains, A, B, C ..., each of which is involved independently in a transition between the 
folded and unfolded forms (A =A \ B=B’, . ..). Equilibrium constants are expressed in terms of 
fractions e.g.
Ka = A ./,
where KA is the equilibrium constant for the unfolding of domain A, fA- and fA are the 
fractions of the unfolded and folded domain A, respectively. Remembering that fA- and fA are 
related simply as follows:
/ ,=!- / , •
The total molar enthalpy for the system, H, is given by:
H  = H „ +  f A.AHA + f s.AHB +. . .  (2.2)
where HN is the total enthalpy of the native state, to which all measurements of AH are 
relative. The total molar heat capacity is the temperature derivative of equation 2.2:
C  =  C  + f AA C pA + AH /
8T
+ (2.3)
where CpN is the molar heat capacity of the totally folded state. Substituting equilibrium 
constants in place of fractional concentrations in equation (2.3) and then carrying through the 
differentiation gives:
f 6 / , ) f  « A ) f  5 In K a \^
{ S T  J { 0  + k a) 2J ST J
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By substituting equations 2.1 and 2.4 into equation 2.3 gives:
C = C  +' - 'p  pN  ~
K AACpA K aAHvHAHa
1 + K a (\ + K a ) r t
+ (2.5)
Equation 2.5 is perfectly general at this point and can be applied to either two-state or non- 
two-state transitions so long as all parameters are evaluated at the same temperature T.
Model for Independent Two-State Transitions
If we assume each transition is two-state, then the van’t Hoff enthalpies (the heat 
uptake per mole of cooperative unit in the transition which is independent of sample 
concentration and absolute calorimetric enthalpy, assuming a two-state transition model) 
become equal to the calorimetric enthalpies (simply the integrated area beneath the peak in the 
DSC endotherm divided by the total amount of protein in the calorimeter cell). If we also 
assume that CpN is a linear function of temperature then equation 2.5 gives:
C ( T )  = B0 + B J  +
K a (T)ACm ' K  A T )  AH AT)
1+ K A T )
+
(l + K A T ) ) 2R T 2
+ (2 .6)
where CP(T), KA(T) and AHa(T) are the heat capacity, equilibrium constant and enthalpy 
change at temperature T, respectively. This can be expressed in terms of the Tm of the 
transition as follows:
A H A T )  = AHmA+ A C J T - T mA) (2.7)
and then integrating the van’t Hoff equation (2.1) from to T gives:
^ ( D  = exp<
- A H mA
RT
1-------
T\  mA
ACpA
RT
T - T ^ - T  In-
mA J
(2 .8)
By substituting equations 2.7 and 2.8 into equation 2.6, the model to which the DSC 
data can be fitted, is obtained. To initiate curve fitting with Origin, the operator indicates the
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number of transitions needed to fit the experimental DSC heat capacity curve and then inputs 
guesses of all the Tm values. The software then fits the data to the model by non-linear least- 
squares until there is no further improvement in fit.
When all heat capacity changes are assumed to be zero, then equations 2.6-2.8 are 
simplified to:
t C A D A H A  TV
p ( \  +  K A T ) )  R T
K a (T) = exp' A//"4
R T
r T \
1-------
TV mA J
(2.10)
Curve fitting is again by non-linear least-squares regression.
Model for Independent Non-Two-State Transitions
Because of the extra fitting parameters required for the non-two-state model 
compared with the two-state model, this model is only applied to transitions with no ACP. 
Before curve fitting with this model, a progress baseline must be subtracted from the 
experimental data to remove the ACP effects if they are present (the accuracy of this progress 
baseline is based on an educated guess/good eye of the operator). This also sets CpN to zero at 
all temperatures. To treat non-two-state transitions we begin with the general equation 2.5 
which still includes both van’t Hoff and calorimetric heat changes. If the temperature- 
dependent parameters are indicated, this can be written as:
C  ( T ) = K ^ T)AHmA^ Hm$ +  ... (2.11)
p (1 +  K A(T))  R T 2
In this case, the equilibrium constants will be calculated as in equation 2.10 with the 
important exception that the van’t Hoff enthalpy must be used rather then the calorimetric 
enthalpy since the two are now no longer equal, i.e.:
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(2 .12)
Equations 2.11 and 2.12 are then used for curve fitting again by non-linear least-squares with 
the operator inputting the number of transitions needed to fit the experimental data and 
guesses for the corresponding Tm values. It is up to the user to decide whether the fit is 
successful; if not the procedure is repeated.
2.2.3 Analysis of Kinetically Controlled Processes
The above analyses of DSC data are only valid if the processes under investigation 
are thermodynamically controlled. If the processes are kinetically controlled, the above 
analyses will result in some kind of error and a form of kinetic analysis must be used. Kinetic 
control is established by the fulfilment of either one (or both) of the two following criteria: 
rescanning of the protein fails to reproduce the original scan (so-called calorimetric 
irreversibility) and/or the scans show scan rate dependence (that is, the Tm and/or the trace 
shape change on changing the scan rate). If the sample meets the above criteria then the 
process is indeed under kinetic control and the data is interpreted using the method proposed 
by Sanchez-Ruiz et al., (1988a).
The rate constant, k, characterising a kinetically controlled process, is dependent on 
temperature. This temperature dependence is governed by the Arrhenius equation:
where A is the pre-exponential factor, EA is the activation energy, R is the gas constant and T 
is temperature. Consider the case of a two-state irreversible denaturation of a protein (based 
on Freire et al., 1990). It can be represented by the first-order equation:
(2.13)
N —^ U
where N and U are the native and unfolded form of the protein respectively and k is the first- 
order rate constant for the process. This can be rewritten as:
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-4«]
dt  dt
or, expressing [N] and [U] as mole fractions PN and Pu where:
P _M  P _ Pd
N  n  ’ r U ~P  PTotal Total
gives:
= k p
dt  N
Temperature dependency is introduced by dividing both sides by the scan rate, v, and 
substituting the Arrhenius equation for the rate constant giving:
dPN A
d T  v
— exp
- E . A
D1RT
PN (2.14)
Notice the term -dPN/dT is equivalent to the change in extent of conversion of native to 
unfolded with temperature.
In kinetics, the Arrhenius parameters are calculated from measurements of the 
temperature dependence of the rate constant for the process under investigation. The method 
devised by Sanchez-Ruiz et al. (1988a) allows for the calculation of the rate constant as a 
function of temperature from experimental DSC data. Using this method, DSC scans at 
different scan rates (the MC-2 system allows 10, 20, 30, 45, 60 and 90 K/hr scans) are 
recorded for the protein (and corresponding buffer). A suitable baseline is then fitted to and 
subsequently subtracted from each scan and each scan normalized to produce a data set of 
apparent excess molar heat capacity versus temperature. Using Origin software we can then 
evaluate the calorimetric enthalpy (although it has no thermodynamic significance for a 
kinetically controlled process it does, however, represent the enthalpy gain or loss for the 
conversion process).
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Values of the rate constant of a reaction at a given temperature, k, are obtained from 
DSC data using the equation:
k =
vC„
(e-a)
(2.15)
where v (K/min) represents the scan rate, Cp the excess heat capacity, Q the total heat of the 
process (proportional to the area below the thermogram) and Qt the heat evolved at a given 
temperature (area below the thermogram between an initial temperature and a desired 
temperature, T). An Arrhenius plot of Ink versus 1/T can then be constructed and the 
activation energy, EA, for the process obtained from the slope of the graph. EA can also be 
calculated from the slopes of the plots of ln[lnQ/(Q-Qt)] versus 1/T according to:
In
InQ - E jl
R T j
(2.16)
where Tm is the temperature corresponding to the maximum of the heat capacity curve and 
ln(v/Tm2) versus 1/Tm according to the following equation:
V
A R ] ( ~ e AIIhs5 j
exp (2.17)
where A is the Arrhenius pre-exponential factor and e is the base of natural logarithms. The 
activation energy can also be calculated directly from the heat capacity at the maximum of the 
trace, Cpmax, according to:
e a =
n o i  2 maxeRT C nm p
Q,
(2.18)
The above method of DSC data analysis is then applied to data recorded at all six available 
scan rates for a full data set.
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The four methods used to calculate the activation energy (eq. 2.15-2.18) use different 
experimental information and involve different approximations. Equation 2.18 uses 
parameters from the maximum of the excess heat capacity curve while equation 2.17 is based 
on the effect of the scan rate on the Tm and equation 2.16 tests the shape of the traces with 
changing scan rate. These three functions assume that the Arrhenius equation holds true 
whereas the method based on equation 2.15 checks that the rate constants calculated from the 
traces obtained at different scan rates agree and is valid even if the Arrhenius equation does 
not hold. Agreement between the results obtained by the four different methods is a crucial 
test of the validity of the proposed kinetic model for the denaturation process.
2.2.4 Extrapolation of DSC Data to Infinite Scan Rates
If the denaturation pathway of a protein is described as the sum of two effects: an 
endothermic effect comprising the energy involved in the destruction of tertiary structure and 
an exothermic effect comprising the energy released on aggregation, then we can theoretically 
analyse each effect separately by extrapolation of the data to infinite scanning rates (La Rosa 
et al., 1995; Milardi et al., 1998). Such analysis is only valid if the experimental DSC curves 
obtained at different scanning rates illustrate that the magnitude of the exothermic effect 
decreases with increasing scan rate (i.e. the exothermic contribution is time dependent) to a 
greater extent than the endothermic effect. It is this difference in the manner that the changing 
scan rate affects the exo- and endothermic peaks that allows the reversible and irreversible 
steps to be considered separately.
Such analysis begins with the calculation of the apparent activation energy for the 
unfolding process using eq. 2.17. The Cp exc (specific excess heat calculated according to 
Privalov and Potekhin, 1986) curve at infinite scanning rate is obtained by means of the 
following procedure: the cumulative enthalpy functions <AH> were calculated from the 
experimental calorimetric profiles obtained at different scan rates using the following 
equation:
where T0 is the temperature at which all molecules are in the initial state. For a first-order 
process, the relationship between <AH>, <AH>rev, T and v is given by the following equation:
(2.19)
28
Chapter 2
( A H - ( A H ) )  = (Aff-(Aff) J e x p l - I j ^ r (2.20)
where AH is the calorimetric enthalpy calculated at the chosen scan rate, <AH>rev is the 
cumulative enthalpy function containing the information pertinent only to the species that are 
in equilibrium, and kapP is the apparent kinetic constant. Clearly when v—>°° then 
<AH>—><AH>rev exponentially.
To obtain the <AH>rev function over the entire denaturation range, the numerical 
values of <AH> at each scan rate for a given temperature are plotted against 1/v and the 
intercept values with the y-axis give the value of <AH>rev at the given temperature. Deriving 
the <AH>rev profile with respect to temperature gives us the Cp exc profile at infinite scanning 
rate which allows the calculation of AH and a Tm for the process under investigation. 
(Further mechanical-statistical analysis of the Cp exc profile via the first derivative of <AH>rev 
with respect to temperature, using the classic deconvolution algorithm of Freire and Biltonen 
(Freire and Biltonen, 1978; Biltonen and Freire, 1978), allows the path of the folding- 
unfolding transition to be established. This further method of analysis was not used in this 
thesis.)
2.3 Protein Analysis
2.3.1 Determination of Protein Concentration
Protein concentrations throughout this thesis were determined spectrophotometrically 
using a Shimadzu UV160A UV-visible recording spectrophotometer using quartz cells with 
pathlength 1 cm. Protein concentrations were determined according to the Beer-Lambert law:
where [c] is the protein concentration in mol/L, A is absorbance, 1 is the pathlength (in cm) 
and 8 is the molar extinction coefficient of the absorbing protein, e for each of the three 
antibodies were obtained by entering the amino acid sequence of each into the ExPASy
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ProtParam tool (point browser to http://www.expasy.ch/tools/protparam.html) which 
calculates e from the algebraic sum of contributions from individual tryptophans, tyrosines 
and disulfides according to the method developed by Gill and Von Hippel (1989). The 
sequence of Campath-IH is as published (Crowe et al., 1992), the sequences of 4162W94 and 
1209W95 were provided by private communication (U.T. Lashmar, 1997). The extinction 
coefficients of the three mAbs are given in table 2.1 below, the molecular weight of all three 
mAbs is taken to be 150 kDa. (Due to glycosylation of these molecules, accurate molecular 
weights derived from sequence data cannot be calculated. Throughout this thesis, all 
calculations involving protein concentrations used molar concentrations (not mg/ml) and 
therefore knowledge of the exact molecular weight was unnecessary.)
mAb £280nm (M'1 C m '')
Campath-IH 132000
4162W94 191000
1209W95 224000
Table 2.1. Summary of extinction coefficients used
2.3.2 SDS-PAGE
The SDS-PAGE gels described in this thesis were cast using a Hoefer Mighty 
Small™ SE245 Dual Gel Caster (Hoefer Scientific Instruments, San Francisco, U.S.) and 
were of 0.75 mm width. Proteins were electrophoresed through 10% SDS-polyacrylamide 
under reducing conditions using a discontinuous buffer system. Lyophilyzed molecular 
weight standards (Pharmacia Biotech) were dissolved in 200 pi deionized H20 . All samples 
were mixed with equal volumes of sample buffer and heated at 100°C for 4 mins to denature. 
After loading onto the gel, electrophoresis was carried out at 150 V, 30 mA. Gels were then 
stained with Coomassie Blue and destained as required.
2.4 Fluorescence Spectroscopy
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The process of fluorescence occurs when a substance absorbs light which excites its 
molecules from a ground state to a higher state only to return to the ground state, reemitting 
light, usually of a longer wavelength than the exciting light. Substances which normally 
exhibit fluorescence are those whose structure contains delocalised electrons as part of a 
conjugated system. The fluorescent compounds of interest when studying biological processes 
can be separated into two camps: intrinsic or naturally occurring fluorophores such as 
tryptophan, tyrosine, phenylalanine, and the disulfide chromophore of cysteine, and extrinsic 
chromophores which include fluorescein and other synthetic probes of which ANS is only one 
of many. The fluorescence of many fluorophores is extremely sensitive to their surrounding 
environments, tryptophan residues in proteins are a case in point, and this allows fluorescence 
to be used as a very sensitive structural probe in many biological systems. The innate 
sensitivity of the technique allows the study of very small quantities of material, often 
allowing quantitative studies on the nanomolar scale to be carried out.
In order for any spectroscopic technique to be used to study a conformational 
transition in a macromolecule, there must be a discernible difference in some signal between 
the two (or more) macroscopic states. The sensitivity of fluorescence signals to the 
microenvironment of the fluorophore qualifies the technique for such studies and since we can 
monitor any of a number of fluorescence signals e.g. fluorescence intensity, quantum yield 
(ratio of the intensity of the fluorescent light to the intensity of the incident light), emission 
maximum, fluorescence lifetime, fluorescence anisotropy, to name a few, it is likely that some 
signal will be sensitive to the conformation of the molecule.
Fluorescence, especially intrinsic tryptophan fluorescence is extremely sensitive to 
temperature and therefore all experiments were performed with the cuvet holder attached to a 
thermostatically controlled water bath and circulator to maintain the desired temperature. All 
measurements were made on a Spex FluoroMax spectrofluorimeter interfaced with a personal 
computer and using square 1 cm quartz cuvets. All sides of these cuvets are optical surfaces 
to allow detection of fluorescence perpendicular to the incident light. Consideration of sample 
concentration is vital in fluorescence experiments as high concentrations of sample can lead to 
inner filter effects. Quite simply this occurs when the sample closest to the source of incident 
light absorbs light such that the sample further on in the pathlength receives less light and 
subsequently the intensity of fluorescence may be decreased by either the lowering of the 
effective intensity of the incident light or by the absorbance of some of the fluorescence. To 
prevent inner filter effects, experiments were carried out at a protein concentration in the
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region of (0.5 jjM). When recording fluorescence spectra, buffer baselines were also recorded 
to ensure not only that the buffer itself was not fluorescent (due to possible contamination) but 
also to allow subtraction of peaks occurring from light scattering and Raman effects. All 
buffer solutions were filtered (0.2 pm pore size) to remove any dust and other particulate 
matter.
2.4.1 Intrinsic Tryptophan Fluorescence Spectroscopy
All experiments were performed by exciting the sample at 295 nm (both tyrosine and 
tryptophan absorb maximally at 280 nm although tryptophan has the higher absorbance at its 
maximum and shows significant absorbance at 295nm whereas tyrosine does not) and 
collecting emission data in the 300-600 nm wavelength range. Data were collected at 1 nm 
increments with the software sampling each wavelengh for 0.3 s and averaging the 
fluorescence intensity.
Experiments involving monitoring the fluorescence intensity as a function of 
temperature required the thermostatically controlled water bath to be adjusted as necessary. 
A digital thermocouple thermometer was also placed in the sample cuvet to monitor the actual 
sample temperature. An approximate heating rate of 60 °C/hr was achieved.
2.4.2 Succinimide quenching
The quenching reaction between the excited state of a tryptophan residue, T*, and a 
quenching agent, Q, can be described as follows (Eftink and Ghiron, 1984):
r* +q — »(r*....q )—^ t +q +a
where (T* Q) is the complex resulting from the diffiisional encounter between T* and Q
with rate constant kd. A is the energy released when the excited state dissipates and kj is the 
rate constant for the radiationless deactivation of the complex.
The Stem-Volmer Law (Stem and Volmer, 1919) is a classical relationship often 
used to analyse data from the collisional process presented above. It relates the drop in 
fluorescence to the concentration of a collisional quencher, [Q]:
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y  = l + ff„[G] = Y  (2.21)
where F0 and F are fluorescence intensities in the absence and presence of quencher 
respectively, To and T are fluorescence lifetimes in the absence and presence of quencher 
respectively and Ksv is the collisional quenching constant (also known as the Stem-Volmer 
constant or coefficient). This relationship is valid for quenching processes involving 
succinimide as the quenching agent as it is a large, relatively inefficient quencher (Eftink and 
Ghiron, 1981; Eftink and Ghiron, 1984). Ksv can be used as a measure of the accessibility of 
tryptophan residues when compared to the Ksv obtained on quenching a solution of L- 
tryptophan in appropriate buffer.
Experimental determination of Ksv involves the following. A 0.5 |iM solution of mAb 
in required buffer is excited at 295 nm and the emission spectrum recorded (a spectrum of 
buffer alone is also recorded under identical conditions). 20 (il aliquots of succinimide 
solution (2.5 M in buffer) are then added and the fluorescence intensity at 330nm recorded 
(Eftink and Ghiron, 1984). A total of 300 |il quencher is added for each experiment and each 
experiment was repeated to check for reproducibility. Fluorescence intensity data are then 
corrected for both buffer effects and dilution. Fo/F is then plotted against succinimide 
concentration, the slope of the graph being equal to Ksv in accordance with the Stem-Volmer 
Law. Ksv for free L-tryptophan in identical buffer is also determined by quenching a 2 mM 
solution in a similar fashion.
2.4.3 Acrylamide Quenching
Acrylamide is a small, organic, uncharged polar quenching agent and is described as 
being an efficient quencher of tryptophanyl fluorescence and is very discriminating in sensing 
the degree of exposure of this residue in proteins (Eftink and Ghiron, 1976a) whereas it has 
been mentioned previously that succinimide is a large and relatively inefficient quencher of 
tryptophan fluorescence. Because the acrylamide molecule is small, polar and uncharged, the 
quenching of buried fluorophores can occur as the molecule finds its way into the interior of 
the protein by making use of dynamic nature of the protein structure.
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One major consideration when using tryptophan as a structural probe in proteins is 
the presence of multiple tryptophan residues causing the fluorescence properties to be 
heterogeneous in nature as there may be energy transfer between the various tryptophan 
residues and each fluorescing group may have its own quenching constant. All three mAbs 
are multi-tryptophan containing proteins but although their quenching data are difficult to 
analyse precisely, useful qualitative information can still be obtained (Eftink and Ghiron, 
1976a).
A complexity which arises when acrylamide is used as a quenching agent is the fact 
that it quenches indole fluorescence by both a dynamic and a static process. Static quenching 
involves the formation of a complex between quencher and fluorophore which predates the 
excitation. Excitation of the fluorophores then results in instantaneous quenching of those 
that are complexed. This mechanism of static quenching is not explained by the collisional 
mechanism of Stem and Volmer and leads to positive deviations in Stem-Volmer plots. A 
modified version of the Stem-Volmer equation that describes quenching data when both 
dynamic and static quenching occur has been devised (Eftink and Ghiron, 1976b).
- ^  = X + K „ [Q \= X- f  (2.22)
where V is the static quenching constant (taken to be 1.5 M'1 for the quenching of tryptophan 
by acrylamide at 25 °C, excitation wavelength 295 nm (Eftink and Ghiron, 1976b)). Thus a 
modified Stem-Volmer plot of [(Fo/FeV[Q])-l] against [Q] gives a straight line with gradient 
Ksv.
Acrylamide absorbs light at 295 nm (the excitation wavelength used during quenching 
experiments) and a correction factor of antilog AOD/2 (where AOD is the incremental 
increase in optical density at the excitation wavelength as quencher is added, and 0.5 cm is the 
effective pathlength of the cell) must be applied for the attenuation of the incident light (Eftink 
and Ghiron, 1976b). This must be determined experimentally. 20 |lL aliquots of 8 M 
acrylamide (Freskgard and Petersen et al., 1998) in required buffer is added to a 1 cm 
pathlength quartz cuvet containing a 0.5 |iM solution of protein in identical buffer. The 
absorbance of the resulting solution at 295 nm is noted after each acrylamide addition over
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five additions. The change in absorbance on each aliquot addition should be constant and is 
taken as AOD.
Quenching experiments are carried out by exciting the protein at 295 nm and 
recording the emission spectmm, then titrating a 0.5 |iM protein solution with 20 |il aliquots 
of 8 M acrylamide until 300 jxl is added, recording the emission spectmm after each addition. 
A 2 mM solution of L-tryptophan is also quenched in the same way to obtain the Ksv of fully 
exposed tryptophan. The fluorescence intensities at 330 nm are then corrected for buffer 
effects, dilution and acrylamide absorbance and the results plotted as a modified Stem-Volmer 
plot ([(Fo/FeV[Q])-l] against [Q]) with the gradient of the line equal to Ksv.
2.4.4 Extrinsic Fluorescence of ANS
The hydrophobic fluorescent probe ANS (8-anihno-l-naphthalene sulfonic acid) is a 
powerful tool for monitoring protein unfolding as it can be used to probe the hydrophobicity 
of a protein surface (Busby and Ingham, 1987). The molecule has a weak fluorescence in 
aqueous solution but this is markedly increased upon binding to hydrated hydrophobic 
surfaces on proteins, and a blue shift in the emission maximum occurs (Ptitsyn et al., 1990; 
Guha and Bhattacharyya, 1995).
For experiments binding ANS to protein, samples were excited at 390 nm and the 
emission spectmm recorded from 400-700 nm using a 1 cm pathlength quartz cuvet. A stock 
solution of 2 mM ANS was prepared by dissolving ANS in the relevant buffer. A spectmm 
of buffer only was obtained for the purpose of subtraction, ANS was then added at a 
concentration of 20 (iM and the spectmm recorded and finally protein was added (0.2 (iM) 
and the final spectmm recorded. All binding experiments, except those involving measuring 
hydrophobicity as a function of temperature, were carried out at 25 °C. Required 
temperatures were achieved by means of a thermostatically controlled water bath and 
circulator.
2.5 Circular Dichroism
Circular dichroism (CD) refers to the differential absorption of the left and right 
circularly polarised components of plane polarised light and is a widely used technique for
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studying peptide and protein conformation (Kelly and Price, 1997). The basis of the 
technique is that a molecule is optically active if it interacts differently with the left and right 
circularly polarised light. Optical activity is only observed if the chromophore is chiral either 
(i) intrinsically, by way of its structure e.g. the peptide bond, or (ii) by being covalently linked 
to a chiral centre or (iii) via interactions from asymmetrically placed neighbouring groups.
When using CD to analyse protein structure, two types of CD can be distinguished. 
First, there is CD related to the protein backbone which is derived from amide-amide 
interactions and second, superimposed on this, there is the CD from the chromophores of the 
aromatic amino acid, the disulfide bond and prosthetic groups etc which are optically active 
either by default, i.e. they ‘sense’ the chirality of the protein backbone, or they may be 
intrinsically chiral.
Near-UV-CD is a powerful technique that can be used for probing small structural 
changes (Freskgard and Petersen et al., 1998). The variation of CD in this wavelength region 
(310-240 nm), for most proteins, is due to the contributions of phenylalanine, tyrosine, 
tryptophan and the disulfide chromophore of cystine. The near-UV region reflects the tertiary 
structure of a protein and although it is not readily amenable to detailed interpretation in terms 
of tertiary structural features, it provides a fingerprint of the native state of a protein.
The far-UV CD spectrum (250-170 nm) is generally used to probe the secondary 
structure of proteins. It is well known that the different forms of regular secondary structure 
found in proteins and peptides exhibit distinct far-UV CD spectra and this knowledge has 
provided a means of taking any observed spectrum and estimating the contributions of the 
different structural forms. For the purpose of this thesis, the quantitative analysis of such 
spectra was unnecessary and qualitative data only was extracted.
CD spectra were recorded at the Scottish CD Facility, University of Stirling (run by 
Prof. N. Price and Dr S. Kelly) on a Jasco J-600 spectropolarimeter fitted with a thermostated 
cell holder connected to a thermostatically controlled water bath and circulator. A heating 
rate of 60 °C was achieved. Cell pathlengths of 0.02 and 1.0 cm were used. All buffer and 
protein solutions were filtered (0.2 |im pore size) prior to use to remove dust and other 
particles. Protein concentrations were typically 6.7 |lM in 0.01M citrate buffer (0.01M Tris 
was used for 1209W95). Buffer baselines were run under identical conditions for the purpose
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of subtraction. Chemical unfolding experiments were carried out at 25 °C, the temperature 
for thermal unfolding experiments was increased by means of the waterbath/circulator and the 
sample temperature monitored using a thermocouple thermometer probe inserted directly in to 
the cell.
2.6 Induced Aggregation Experiments
Experiments to monitor the effect of preformed aggregate on the rate of thermal 
aggregation of Campath-IH took two forms. Firstly the rate of aggregation was studied by 
using UV/visible spectrophotometry to measure the absorbance of protein solutions at 280 nm 
(and hence measure protein concentration (see section 2.3.1)) and the turbidity of the solutions 
at both 320 and 400 nm, and secondly, activation energies and rate constants for the process 
of thermal denaturation in the presence of preformed aggregate were calculated using the 
method described in section 2.2.3 and compared to the values in the absence of preformed 
aggregate presented in table 4.7.
The first type of experiments were performed as follows. 1 ml aliquots of a 0.009 
mM solution of Campath-IH (pH 6 CBS) were incubated over a period of days in a 
thermostatically controlled waterbath at certain temperature at which the folded form of the 
protein was deemed unstable (i.e. below the Tm of main transition endotherm as observed by 
DSC). 60, 65, and 70 °C were used in separate trials. Half the samples contained either 5, 
10 or 20 pi of a dispersed solution of aggregated Campath-IH (prepared by heating an aliquot 
of Campath-IH (0.009 mM, pH 6 CBS) to 85 °C). At specific time intervals, nominally 
every 24 hours, 200 pi was removed from each sample, centrifuged for 5 mins at 13 000 
r.p.m. and the absorbance of the supernatant at 280 nm recorded. The absorbance was then 
plotted against time for each of the controls and the samples with 5, 10 and 20 pi of added 
aggregate.
Experiments involving the measurement of solution turbidity were performed in a 
similar manner: Samples of a Campath-IH solution (0.009 mM, pH 6 CBS) were incubated 
at a range of temperatures between 65 and 75 °C. A number of these samples were ‘seeded’ 
by the addition of either 0.5, 1, 5 or 10% (v/v) of a solution of preformed aggregate. Over a 
period of 500 minutes, the turbidity of the solutions were recorded by measuring the
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absorbance of the solutions at 320 and 400 nm. The absorbance was then plotted against 
time.
The second type of experiments, those in which the activation energies and rate 
constants for the denaturation process are calculated were performed as described in section
2.2.3 the only difference being the sample in the calorimeter cell contained an amount of 
preformed aggregate. Results were obtained for Campath-IH in pH 4 ABS with 0.2% (v/v) 
of preformed aggregate solution added and for Campath-IH in pH 5 CBS with 0.6, 1.0, 1.4 
and 2.0% (v/v) of preformed aggregate solution added (only very small amounts of preformed 
aggregate were added as the presence of insoluble particulate matter in the DSC cell results in 
baseline noise).
2.7 Long-Term Storage Sample Preparation
Long-term storage samples were prepared by dialysing the protein into the desired 
buffer/additive formulation. The bulk filling solutions were then passed through a 0.22 p,m 
sterilising grade filter and 1 ml (nominal volume) aliquots collected in sterile neutral glass 
vials and stoppered with sterile latex caps and then finally sealed with sterile crimped 
aluminium seals. The complete filling procedure was carried out within a laminar flow 
cabinet. Vials were then labelled and stored at 4 °C in darkness for 2 years.
2.8 Isothermal Calorimetry
The VP-DSC has two basic modes of operation; scanning (conventional DSC) and 
isothermal. A description of the DSC mode is given in sections 2.1.1 and 2.2.2. In isothermal 
mode, constant temperature is maintained for relatively long periods of time while measuring 
differential power between the reference and sample cells (the duration of the experiment is 
limited only by PC disc space). All measurements were carried out for a duration of 24 hours 
with a filter setting of 60 s.
Sample preparation and filling is identical to the DSC mode with the exception that 
relatively high protein concentrations are necessary (in the region of 0.03-0.10 mM) and
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buffer baseline experiments are still performed. Again the data are analysed using MicroCal 
Origin 5.0 software.
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CHAPTER 3
THERMAL UNFOLDING OF MONOCLONAL ANTIBODIES
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3.1 Introduction
The thermal unfolding of mAbs is of great interest to the pharmaceutical industry due 
to their interest in developing them as possible therapeutic targets. mAb functionality is 
directly linked to their antigen binding abilities which are determined by their structural 
features. DSC has been used in the past to monitor thermal events occurring when these 
polyglobular glycoproteins unfold (Tischenko et al., 1982; Loseva, 1986; Kravchuk, 1998) 
and deconvolution of DSC data to obtain information about individual domain events has 
been attempted (Tischenko et al., 1982) and comparisons to data obtained from electron 
microscopy data made (Ryazantsev et al., 1990). Other studies of thermal stability have 
utilised CD and capillary electrophoresis (Kats et al., 1995), micellar electrokinetic capillary 
chromatography (Kats et al., 1997), capillary isoelectric focusing (Dai et al., 1998), and 
matrix-assisted laser desorption/ionization mass spectrometry (Alexander and Hughes, 1995).
A common problem in previous work, which leads to some disagreement between 
publications from different groups, is the assignment of multiple calorimetric endotherms (or 
rather many sharper endotherms representing two-state transitions which have been arrived at 
via deconvolution of one or two broad endotherms from the experimental DSC profile), to the 
unfolding of individual IgG domains. Tischenko et al., (1982) fit DSC data to seven 
cooperative transitions in an IgG molecule with twelve domains whereas Kravchuk et al., 
(1998) fit DSC data to six or five simple two-state transitions. In this chapter, such 
controversial fitting (and deconvolution) of DSC data is avoided. The purpose of the work 
presented in this chapter is to present a comprehensive analysis of the thermal unfolding of the 
three mAbs; Campath-IH, 4162W94 and 1209W95, using data obtained from DSC, CD and 
fluorescence spectroscopy experiments. The work is an attempt to understand the effects of 
elevated temperatures on these proteins and to investigate how unfolding information gained 
using different techniques is related.
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3.2 Results
3.2.1 DSC Data
The pH dependence of the thermal stability was investigated by obtaining the DSC 
profiles of the three mAbs at a range of pHs (scans were all carried out at a nominal scan rate 
of 60 °C/hr unless stated otherwise). In the case of Campath-IH scans in, 0.1 M CBS pH 3, 
4, 5 and 6, ABS pH 4, and PBS pH 7.1 were recorded. No difference was observed in trial 
scans if pH4 ABS was replaced with pH4 CBS so pH4 ABS was normally used throughout. 
Figure 3.1a shows the effect of pH on the DSC profiles of Campath-IH with the 
corresponding Tm values presented in table 3.1. Initial experiments were repeated several 
times, however results were very consistent (typical errors on the Tm values were ±0.1 °C). 
Figure 3.1b shows a plot of Tm versus pH and the resultant curves are typical of the titration 
of carboxylate residues. DSC scans were always repeated to check for any calorimetric 
reversibility but none was observed (unless otherwise stated). Above pH 6, Campath-IH 
produced a single asymmetric endotherm, the asymmetry being caused by a sharp exothermic 
peak on the high temperature side of the main endotherm and a shoulder on the low 
temperature side. As pH is decreased, the Tm of both the main endotherm and the shoulder 
decrease in such a manner that the shoulder becomes a discrete small endotherm and also the 
exothermic peak is not observed at pH 4 and below. If the exothermic peak is present on the 
DSC profile, when removed from the instmment, the sample had invariably aggregated (this 
aggregation is also the cause of noisy posttransition baselines as the precipitated protein is 
involved in erratic convection effects within the calorimeter cell) and therefore it was decided 
to carry out thermal unfolding experiments using CD and fluorescence spectroscopy at pH 3.5 
to prevent aggregation of the molecule at elevated temperatures.
DSC profiles of 4162W94 were recorded at pH 3-6 and results are shown in figure
3.2 with corresponding Tm values in table 3.2. The DSC profile of 4162W94 at pH 6 is very 
similar in shape to those of Campath-IH at pH > 6, though if the buffer is made more acidic, 
the exothermic peak is no longer observed and two more small endotherms appear on the high 
temperature side of the main endotherm. Again, the exothermic peak was indicative of gross 
thermal aggregation of the sample and further investigations into thermal unfolding were 
carried out at pH 3 so that gross aggregation would not occur.
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In the case of 1209W95, DSC scans were recorded at pH 6.6 and 8 (protein visibly 
aggregated outside this pH range), DSC scans and Tm values are presented in figure 3.3 and 
table 3.3 respectively. DSC profiles of 1209W95 throughout this pH range consisted of one 
large asymmetric endotherm, foreshortened its high temperature side by a sharp exothermic 
peak consistent with aggregation of the sample.
DSC transitions were also analysed using a successive annealing technique which 
checks the reversibility of individual endotherms and exposes any small endotherm hidden 
‘beneath’ larger endotherms (Shnyrov and Mateo, 1993, Kreimer et al., 1995, Shnyrov et al., 
1996). The results of this technique for Campath-IH, 4162W94 are presented in figures 3.4 
and 3.5 respectively (1209W95 was also investigated using this technique but the sample 
invariably aggregated before any relevant data could be collected). The first endotherm of 
Campath-IH is reversible at pH 3.5 (as long as the temperature is not raised above that of the 
Tm of the second endotherm) and the fourth endotherm of 4162W94 (pH 3) is reversible 
though the degree of reversibility decreases with successive heating cycles, as shown in figure 
3.6.
3.2.2 CD Data
In order to assist with the interpretation of the structural events occurring on heating, 
which are evident from DSC profiles, both near- and far-UV CD spectra for each mAb were 
collected at a range of temperatures. These CD spectra were used qualitatively to monitor 
structural changes. To avoid thermal aggregation occurring while CD spectra were being 
recorded at elevated temperatures, buffer pH was chosen to prevent such aggregation based 
on results from low pH DSC experiments. To minimise buffer absorbance, dilute buffers (10 
mM) were used to maintain pH and buffer components which contain chloride ions were 
omitted as Cl' ions absorb strongly below 195 nm (Kelly and Price, 1997). ‘Blank’ CD 
spectra of buffer only were also run to ensure buffer components did not lead to excessive 
noise or other artefacts in the spectra.
CD spectra of Campath-IH (pH 3.5), 4162W94 (pH 3) and 1209W95 (pH 8) were 
recorded over a temperature range of 25-65 °C (waterbath/circulator set-up could not reach 
and maintain higher temperatures). The results of these experiments are shown in figures 3.7,
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3.8 and 3.9 for Campath-IH, 4162W94 and 1209W95 respectively. Spectra recorded at 
every temperature are not plotted, only a sample of relevant recorded spectra are presented.
As can be seen from figure 3.7a (near-UV CD spectra), monitoring changes in the 
molar elipticity at 295 nm (a wavelength at which the CD of most proteins is sensitive to 
changes in tertiary structure) reveals a small but significant change in tertiary structure 
between 25 and 50 °C followed by a collapse of tertiary structure between 50 and 65 °C. 
Monitoring the molar elipticity at 225 nm as shown in figure 3.7b (far-UV CD spectra) 
reveals changes within the secondary structure of the molecule i.e. changes in the strong 13- 
sheet signal typical of IgGs (Kats et al., 1995). It shows no change in the secondary structure 
of the molecule below 50 °C though above this temperature there is a major change where in 
fact all secondary structure is lost.
Similar changes are observed with 4162W94. The near-UV CD spectrum (fig. 3.8a) 
as monitored at 295 nm reveals an initial change in tertiary structure at approximately 48 °C 
followed by another change above 60 °C which results in loss of all tertiary structure. The 
far-UV CD spectrum (fig. 3.8b) as monitored at 225 nm reveals no change in secondary 
structure below 45 °C but at higher temperatures there is a major change which results in loss 
of secondary structure.
The near-UV CD spectrum of 1209W95 (fig. 3.9a) reveals changes in tertiary 
structure at approximately 55 °C with loss of tertiary structure occurring by 60 °C. The far- 
UV CD spectrum (fig. 3.9b) reveals secondary structural changes coincident with these 
tertiary structure changes. By 60 °C, the sample of 1209W95 used for CD measurements had 
visibly aggregated.
3.2.3 Fluorescence Spectroscopy
3.2.3.1 Intrinsic Tryptophan Fluorescence
Using intrinsic tryptophan fluorescence as a probe to monitor structural changes, 
fluorescence emission spectra of the three mAbs as a function of temperature were recorded. 
Again we attempted to carry out experiments with proteins buffered at pHs which prevented 
gross thermal aggregation as such aggregation and the resultant turbidity of the solution
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would prevent measurement of the spectra. Therefore Campath-IH was buffered at pH 3.5, 
4162W94 at pH 3 and 1209W95 at pH 8 and the spectra recorded from 25-70 °C. The 
fluorescence intensity at 350 nm (excitation X was 295 nm) was then plotted as a function of 
temperature and figures 3.10 and 3.11 show data for Campath-IH and 4162W94 
respectively. (1209W95 repeatedly aggregated before any relevant data could be obtained 
therefore no data are shown). The fluorescence spectrum of a solution of free tryptophan in 
relevant buffer as a function of temperature was used as a control experiment.
Figure 3.10 shows two points inflection arrowed at approximately 41 °C and 63 °C 
indicating changes in the polarity of the environment of Campath-IH tryptophan residues at 
these temperatures. Figure 3.11 shows three points of inflection at 38 °C, 48 °C and 60 °C 
again representing changes in the polarity of the environment of the tryptophan residues 
within 4162W94. All chosen points of inflection are positive. The fluoresence intensity 
decreases at high temperatures probably due to photobleaching and/or a reduction in quantum 
yield caused by incresed thermal energy.
Measurements of intrinsic tryptophan fluorescence were also recorded before and 
after DSC scans. The emission spectrum (excitation X, was 295 nm) of Campath-IH (pH 4) 
has a maximum emission intensity at 335 nm but after heating to 100 °C in the DSC cell this 
maximum becomes red shifted to 347 nm, similarly there is a red shift from 339 nm to 348 
nm with 4162W94 (pH 3). Again the aggregation of 1209W95 during DSC scans precluded 
such experiments.
3.2.3.2 Extrinsic Fluorescence of ANS Binding
In a similar fashion to the intrinsic tryptophan fluorescence experiments described in 
section 3.2.3.1, the binding of ANS to the three mAbs, as a function of temperature was 
recorded by monitoring the fluorescence emission of ANS. The binding of ANS to free 
tryptophan, in solution in the relevant buffer, as a function of temperature was used as a 
control experiment. These data revealed the temperature-induced changes in the 
hydrophobicity of the protein surface. Data were plotted as graphs of fluorescence intensity 
at 480 nm (excitation X was 390 nm) as a function of temperature. The results pertaining to 
Campath-IH, 4162W94 and 1209W95 are presented as figures 3.12a, 3.12b and 3.12c 
respectively.
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Figure 3.12a shows two transitions in ANS binding to Campath-IH at approximately 
50 °C and 70 °C. ANS binding to 4162W94 reveals a transition with a midpoint at 
approximately 48 °C as shown in figure 3.12b. Such ANS binding also indicates the 
irreversibility of thermal denaturation as on cooling the sample of 4162W94 back to room 
temperature, the fluorescence intensity returns to a much higher value. This is consistent with 
the irreversible nature of the transition (Ingham et al., 1993). The denaturation curve 
produced when ANS binds to 1209W95 has a midpoint at approximately 60 °C, as illustrated 
in figure 3.12c, though the sample did aggregate before the experiment was completed.
The ability of Campath-IH and 4162W94 to bind ANS was measured before and 
after DSC scans. When excited at 390 nm, ANS in the presence of Campath-IH (pH 3.5) has 
an emission maximum at 490 nm whereas in the presence of Campath-IH which has been 
heated to 100 °C in the DSC cell, ANS has an emission maximum of 479 nm with a 
corresponding increase in fluorescence intensity. Similarly the emission maximum of ANS in 
the presence of 4162W94 is blue shifted from 488 nm to 476 nm on heating the protein to 100 
°C.
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3.3 Discussion
Despite previous reports suggesting that mAbs thermally unfold by sequential domain 
unfolding (Tischenko et al., 1982) the results presented in this chapter indicate that this may 
not be the case. DSC experiments have shown that when Campath-IH is heated there are two 
main thermal events, both endothermic; a small ‘pre-transition’ endotherm and a larger 
endotherm at a higher temperature whereas 4162W94 produces four endotherms in total but 
again the largest main endotherm is preceded by a smaller ‘pre-transition’ endotherm 
(1209W95 will be discussed separately at the end of this section). DSC has also 
demonstrated that the first transition of Campath-IH is calorimetrically reversible (at pH 3.5) 
as long as heating cycles do not involve temperatures higher than the Tm of the main transition 
and similarly the fourth endotherm of 4162W94 shows a degree of calorimetric reversibility 
which decreases with successive heating cycles. The reversibility of this particular transition 
is interesting in that the Tm of the endotherm apparently decreases with each cycle.
Both intrinsic tryptophan fluorescence spectroscopy and monitoring the 
hydrophobicity of the proteins using ANS, as a function of temperature correlate with the 
DSC data in so much as they reveal changes to the proteins occurring at temperatures in the 
same regions of the Tms of the endotherms gained from DSC experiments. Intrinsic 
tryptophan fluorescence experiments reveal that for both Campath-IH and 4162W94, the 
‘pre-transition’ peak and main endotherm represent events which involve subtle changes in the 
environments of the tryptophan residues within the molecules. ANS binding experiments with 
Campath-IH reveal two maxima of binding again in the region of the Tms of the transition 
evident from DSC experiments and also at comparable temperatures to those which induce 
changes in the tryptophan environment as revealed by intrinsic tryptophan fluorescence 
results. 4162W94 and 1209W95 have only one ANS binding maximum at temperatures 
which again correlate with the main transition from their respective DSC traces.
CD spectra of all three mAbs are most informative when we ask the question of what 
structural changes are occurring at these relevant temperatures. Using CD we can show that 
there are crucial similarities in the manner that the three molecules react to thermal treatment. 
Campath-IH and 4162W94 have very similar behaviour; both undergo a small change in 
tertiary structure, probably some domain rearrangement, followed by a major change in both 
tertiary and secondary structure which results in all loss of tertiary and secondary structure.
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The possibility of the first transition representing some domain rearrangement is in agreement 
with work by Privalov (1982) which suggested that the first transition observed when the Fab 
fragment of an immunoglobulin unfolds is either due to the disruption of the contact between 
nonequivalent domains or one of the two types of the domains in the Fab fragment has a 
subdomainial structure as in Bence-Jones protein. 1209W95 differs in that its structural 
changes are not discrete events. It undergoes gradual changes in tertiary structure on heating 
which are eventually superimposed on changes in secondary structure at higher temperatures. 
These changes eventually lead to aggregation of the protein.
It is clear from the CD spectra of 4162W94 that at temperatures above that of the Tm 
of the second transition there is no recognisable tertiary or secondary structure, yet, it is 
evident from the DSC traces that there are a further two endothermic thermal events 
occurring, one of which shows some degree of reversibility. Both intrinsic tryptophan 
fluorescence and the extrinsic fluorescence of ANS binding fail to provide any useful data 
pertaining to these events. We have also shown that none of the four endotherms show any 
concentration dependence (see Chapter 4) which suggests that the peaks are not the result of 
the dissociation of dimers or other oligomeric aggregates. Clearly this apparent discrepancy 
between results gained by DSC and those from CD requires further investigation to shed more 
light on the subject.
In conclusion, CD, intrinsic tryptophan fluorescence and the binding of ANS have 
shown that the first endotherm in the case of Campath-IH and 4162W94 is due to some small 
change in the tertiary structure of the molecule, we propose some form of domain 
rearrangement. The second (main) endotherm has been shown to represent the loss of both the 
tertiary and secondary structure of the molecules. This was achieved by using intrinsic 
tryptophan fluorescence spectropscopy to probe the changes occurring in the environment of 
the tryptophan residues of the mAbs as temperature is increased and by monitoring changes in 
the hydrophobicity of the molecules as temperature increased using ANS as a hydrophobic 
fluorescent probe. CD was used as a synergistic technique to reveal the temperature induced 
structural changes in more detail. Near-UV CD spectra provided information on the tertiary 
structure of the proteins while far-UV CD spectra completed the unfolding picture by 
providing information on the changes in secondary structure. Discrete thermal transitions 
were distinguishable by both techniques.
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1209W95 proved to behave slightly differently from the other two antibodies. CD did 
reveal that, when heated, the molecule did undergo changes in tertiary structure followed by 
major changes in tertiary and secondary structure but unlike Campath-IH and 4162W94, this 
process was continuous with no real distinction between the temperatures at which these 
processes commenced and finished. The DSC too revealed only one endotherm within the pH 
range that was investigated. It is not unreasonable to suggest that at lower pHs the processes 
may become discrete in a similar fashion to Campath-IH on going from pH 7.1 to pH 3.5 but 
the aggregation propensity of the molecule outside the pH 6.6-8.0 range precluded 
experimental proof of this theory.
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pH Tml  (°C) Tm2 (°C)
3.0 _(3) 48.6
3.5 40.9 63.1
4.0 52.6 71.4
5.0 63.4 77.1
6.0 69.4 78.2
7.1 70.6 77.2
8.0 71.6 77.1
Table 3.1: Tm values for Campath-IH over the 3.0-8.0 pH range. (a) Only one large
endotherm (Tm= 48.6 °C) was apparent from the DSC trace. All DSC scans were performed
at 60 °C/hr. Errors on Tm values were typically ±0.1 °C.
pH Tml  (°C) Tm2 (°C) Tm3 (°C) Tm4 (°C)
3.0 46.0 48.6 60.7 72.8
4.0 50.2 65.6 (-) (-)
5.0 63.1 75.1 (-) (-)
6.0 71.3 77.1 (-) (-)
Table 3.2: Tm values for 4162W94 over the 3.0-6.0 pH range. (-) indicates exothermic 
aggregation at temperatures above Tm2. All DSC scans were performed at 60 °C/hr. Errors 
on Tm values were typically ±0.1 °C.
pH Tm (°C)
6.6 60.0
8.0 61.3
Table 3.3: Tm values for 1209W95 at pH 6.6 and 8.0. All DSC scans were performed at 60 
°C/hr. Errors on Tm values were typically ±0.1 °C.
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Figure 3.1a: Raw DSC data for Campath-IH (0.013 mM) in a range of pH conditions (pH
3.0-7.1) scanned at a nominal scan rate of 60 °C/hr. Buffer baseline scans have been
subtracted and scans are y-offset for clarity.
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Figure 3.1b: Plots showing the variation of Tm with pH for Campath-IH (0.013 mM). Tml
and Tm2 are the midpoints of the lower and higher temperature endotherms respectively as
observed in the DSC scans presented in Figure 3.1a.
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Figure 3.2: Raw DSC data for 4162W94 (0.013 mM) in a range of pH conditions (pH 3.0-
6.0) scanned at a nominal scan rate of 60 °C/hr. Buffer baseline scans have been subtracted
and scans are y-offset for clarity.
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Figure 3.3: Raw DSC data for 1209W95 (0.013 mM) in two pH conditions (pH 6.6 and 8.0)
scanned at a nominal scan rate of 60 °C/hr. Buffer baseline scans have been subtracted and
scans are y-offset for clarity.
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Figure 3.4: Raw DSC results of successive annealing of Campath-IH (0.013 mM, pH 3.5) 
showing calorimetric reversibility of first endotherm. Scans were performed at a nominal 
scan rate of 60 °C/hr, buffer baseline scans have been subtracted and scans are y-offset for 
clarity.
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Figure 3.5: Raw DSC results of successive annealing of 4162W94 (0.015 mM, pH 3). 
Scans were performed at a nominal scan rate of 60 °C/hr and scans are y-offset for clarity. 
Buffer baseline scans have been subtracted.
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Figure 3.6: Raw DSC data showing three successive scans of 4162W94 (0.015 mM, pH 3) 
revealing partial calorimetric reversibility of the fourth endotherm. Scans were performed at 
a nominal scan rate of 60 °C/hr, are y-offset for clarity and are shown after baseline 
subtraction.
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Figure 3.7a: Near-UV CD spectra of Campath-IH (6.7 (iM, pH 3.5) recorded at a range of
temperatures (25-65 °C).
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Figure 3.7b: Far-UV CD spectra of Campath-IH (6.7 |iM, pH 3.5) recorded at
temperatures (25-65 °C).
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Figure 3.8a: Near-UV CD spectra of 4162W94 (6.7 |iM, pH 3) recorded at a range of
temperatures (25-65 °C).
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Figure 3.8b: Far-UV CD spectra of 4162W94 (6.7 |LlM, pH 3) recorded at a range of
temperatures (25-65 °C).
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Figure 3.9a: Near-UV CD spectra of 1209W95 (6.7 |iM, pH 8) recorded at a range of
temperatures (25-60 °C).
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Figure 3.9b: Far-UV CD spectra of 1209W95 (6.7 |iM, pH 8) recorded at a range of
temperatures (25-60 °C).
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Figure 3.10: Fluorescence intensity, I, (as measured in counts per second (cps) at 350 nm) of 
Campath-IH (0.5 |iM, pH 3.5) plotted as a function of temperature. Excitation wavelength is 
295 nm. Graph shows two points of inflection (arrowed) at 41 and 63 °C.
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Figure 3.11: Fluorescence intensity, I, (as measured in counts per second (cps) at 350 nm) of 
4162W94 (0.5 (iM, pH 3) plotted as a function of temperature. Excitation wavelength is 295 
nm. Graph shows three points of inflection (arrowed) at 38,48 and 60 °C.
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Figure 3.12a: Effect of thermal denaturation of Campath-IH on fluorescence of ANS.
Measurements were made at a protein concentration of 0.2 fiM in 0.1 M acetate buffer, pH 4, 
0.051 M NaCl containing 20 jiM ANS. The fluorescence emission at 480 nm was monitored 
as a function of continuously increasing temperature with excitation at 390 nm. The arrows 
at 50 °C and 70 °C designate the midpoints of the denaturation curves.
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Figure 3.12b: Effect of thermal denaturation of 4162W94 on fluorescence of ANS.
Measurements were made at a protein concentration of 0.2 pM in 0.1 M citrate buffer, pH 3, 
0.051 M NaCl containing 20 (iM ANS. The fluorescence emission at 480 nm was monitored 
as a function of continuously increasing temperature with excitation at 390 nm. The arrow at 
48 °C designates the midpoint of the denaturation curve. O represents data obtained after 
cooling to 25 °C and then reheating to 80 °C.
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Figure 3.12c: Effect of thermal denaturation of 1209W95 on fluorescence of ANS.
Measurements were made at a protein concentration of 0.2 |iM in 0.1 M Tris buffer, pH 8, 
0.051 M NaCl containing 20 (iM ANS. The fluorescence emission at 480 nm was monitored 
as a function of continuously increasing temperature with excitation at 390 nm. The arrow at 
60 °C designates the midpoint of the denaturation curve. Sample aggregated during the 
experiment.
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CHAPTER 4 
KINETIC ANALYSIS OF UNFOLDING
Chapter 4
4.1 Introduction
Traditional analysis of DSC data to obtain a complete energetic characterisation of 
the stability of a protein molecule, including the overall thermodynamic parameters such as 
transition enthalpies, entropies and temperatures, requires that the system under study should 
be in thermodynamic equilibrium (Privalov, 1974; Privalov and Khechinashvili, 1974; 
Sturtevant, 1974; Shnyrov et al., 1997). The equilibrium criterion usually applied is the 
reproducibility of the original DSC trace on a second heating of the sample, the so-called 
calorimetric reversibility. Irreversibility in protein denaturation is usually attributed to some 
form of alteration that locks the protein in a final state that is unable to fold back to the native 
structure, for example, autolysis or aggregation (Shnyrov et al., 1997). These irreversible 
alterations are fundamentally kinetically controlled processes which must be described by rate 
equations. It was previously thought that such alterations were slow enough on the timescale 
of a DSC experiment to allow equilibrium thermodynamic analysis of irreversible DSC 
transitions (Sturtevant, 1987; Baker and Agard, 1994; Manly et al., 1985; Sanchez-Ruiz, 
1992; Lepock et al., 1990). However experimental work has shown that many irreversible 
DSC transitions are subject to distortion by the kinetics of the irreversible alterations 
illustrated by obvious scanning rate effects (Sanchez-Ruiz et al., 1988a; Sanchez-Ruiz et al., 
1988b; Morin et al., 1990; Galisteo et al., 1991; Conejero-Lara et al., 1991a; Conejero-Lara 
et al., 1991b; Galisteo and Sanchez-Ruiz, 1993; Le Bihan and Gicquaud, 1993; Garda-Salas 
et al., 1996; Davoodi et al., 1998) and possibly exothermic effects caused by aggregation. 
Kinetic analysis of these DSC transitions can be carried out according to the methods devised 
by Sanchez-Ruiz et al.( 1988a).
It is clear from the data presented in chapter three that the thermal unfolding of the 
three mAbs proceeds via an irreversible process (exothermic aggregation peaks on the DSC 
traces and calorimetric irreversibility as illustrated by successive annealing, results presented 
in this chapter will also demonstrate the high scan rate dependence of the scans) and therefore 
the data have been analysed by the aforementioned method developed by Sanchez-Ruiz et al 
(1988a). Such analysis allows the calculation of activation energies and rate constants for the 
process under investigation at a given temperature in addition to the calorimetric and van’t 
Hoff enthalpies determined by fitting the experimental DSC data to non-two state transitions.
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If the rate constants for a particular process over a range of temperatures are 
available, the calculation of half life (tm) is a simple process (l\n =ln2/k, if k is a first order 
rate constant) and theoretically, the availability of such kinetic parameters would allow for the 
quantitative extrapolation of thermal stability results to untested conditions (or conditions 
which give data unsuitable for analysis e.g. pHs which result in DSC traces heavily distorted 
by aggregation phenomena) which is data unattainable from functional assays (Brouillette et 
al., 1996). Such a method of predicting half lives would be of benefit to the pharmaceutical 
industry as it would allow the effective shelf life of any protein pharmaceutical in any 
formulation to be calculated in advance of long-term storage studies.
In this chapter we have also attempted to analyse the DSC data from Campath-IH 
(for this analysis we view this mAb as a model system simply due to its predictable 
behaviour, ease of handling and availability) by viewing the denaturation process as separate 
reversible and irreversible processes. This is achieved by mathematical extrapolation of the 
data to infinite scanning rate and allows the calculation of kinetic and thermodynamic 
parameters associated with the denaturation steps (La Rosa et al., 1995; Milardi et al., 1998).
The results of these methods of analysis of the DSC data of the mAbs will be 
discussed and the accuracy and relevance of the methods to these mAbs which are large, 
complex molecules will be considered.
(Note: Although the calorie is not an SI unit, it is still current in much of the literaure 
pertinent to the subject of DSC analysis- especially from the USA. MicroCal instruments and 
software are calibrated in calories and so the majority of the results presented in this chapter 
are in kcal mol'1. Some theoretical analysis within this chapter yield results in kJ mol'1 but 
where this occurs, the equivalent value in kcal mol'1 is given in parentheses to avoid potential 
confusion. 1 cal = 4.184 J.)
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4.2 Results
In order to carry out a full kinetic analysis of unfolding, it must be shown that the 
system under study is indeed irreversible and subject to kinetic control. In addition to data 
presented in chapter 3 revealing calorimetric irreversibility of protein unfolding (as shown by 
successive annealing) and obvious irreversible aggregation effects, kinetic control can also be 
revealed if the DSC transitions show strong scanning rate effects (Sanchez-Ruiz et al., 1988a; 
Galisteo et al., 1992). Figure 4.1 shows the DSC profiles of Campath-IH (pH 3) at six 
different scanning rates ranging from 10.7 to 72.3 °C/hr. It is evident that the temperature 
corresponding to the heat capacity maximum, Tm, is highly scan rate dependent (this high scan 
rate dependence is a common feature of all three mAbs and the effect of scan rate on the 
unfolding of 4162W94 and 1209W95 can be observed by looking at the variation of Tm with 
scan rate as tabulated in table 4.4 for 4162W94 and table 4.5 for 1209W95) and this suggests 
that the final denaturation process is rate-limited.
A prerequisite to kinetic analysis of the denaturation process as described in section 
2.2.3, is a large quantity of experimental DSC data. The method devised by Sanchez-Ruiz et 
al (1988a) requires that the Tm, calorimetric enthalpy (AHcai), exact scan rate and the heat 
evolved at any given temperature be known for the process under study. The Tm and AHcai are 
determined by non-two state curve fitting using Origin software (AHvH, the van’t Hoff 
enthalpy is also calculated by this process) (Note: if precipitation occurs in the course of a 
scan, the post-transition baseline tends to be very noisy due to erratic convection effects 
within the calorimeter cell. This phenomenon invalidates post-transtion experimental DSC 
data when curve fitting is attempted.) and the results for: Campath-IH in pH 3, 4 and 5 are 
presented in tables 4.1, 4.2 and 4.3 respectively, 4162W94 (pH 3) are presented in table 4.4, 
and 1209W95 (pH 6.6) are presented in table 4.5. These tables also contain the enthalpy 
ratio AHvh/AHcai which, under reversible conditions, is an index of the cooperativity of the 
transition. The kinetic model upon which this method is based is unimolecular and therefore 
is independent of concentration. DSC scans were recorded for sequential dilutions of 
Campath-IH (pH 6) to investigate the presence of any concentration dependence of thermal 
aggregation. Data was recorded for 0.026,0.006,0.002, and 0.001 mM samples using a scan 
rate of 39.8 °C/hr. Gross thermal aggregation occurred at a similar temperature at all 
concentrations and the apparent Tm stayed constant (approx. 77 °C) as shown in figure 4.2, 
proving the process is independent of concentration. A similar analysis was carried out on the
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first endotherm of Campath-IH in pH 4 ABS. DSC scans of 0.018, 0.007, and 0.004 mM 
solutions of Campath-IH in pH 4 ABS were recorded, the data normalised and fitted to a non- 
two state transition and the corresponding Tms, calorimetric and van’t Hoff enthalpies are 
presented in table 4.6. These data show the process which produces this endotherm is 
concentration independent.
Activation energies and rate constants are calculated using equations 2.15-2.18. 
Graphs produced using equations 2.15-2.17 for Campath-IH (pH 3) are shown in figure 4.3 
as an example of the data produced. Similar graphs must be plotted for each transition 
undergoing analysis though these data are not shown. The calculated activation energies for 
each transition, calculated using each of the four equations (equation 2.15-2.18) analysed are 
presented in table 4.7.
In the process of deriving EA using equation 2.15, the rate constant (k) for the process 
under investigation is calculated at a range of temperatures. Assuming that the denaturation 
process is a first order process, the extrapolated half-life of the molecule can then be 
calculated at any given temperature using the relationship, ti/2=ln2/k. Figure 4.4 consists of 
graph plotted as the extrapolated half-life of Campath-IH at 20 °C against pH. The actual 
numerical values of the extrapolated half-lives plotted are 615, 7 .5xl07 and 3 .0xl012 days in 
pH 3, 4 and 5 respectively.
The denaturation of Campath-IH (pH 3) was then analysed by extrapolating the data 
contained in table 4.1 to infinite scanning rate according to the method described by La Rosa 
et al., 1995 and Milardi et al., 1998. The first step in the process is the calculation of the 
cumulative enthalpies <AH> at different scanning rates using equation 2.19. A graph of these 
cumulative enthalpies as a function of temperature is shown in figure 4.5a. Exponential plots 
of the cumulative enthalpies of denaturation versus 1/v (v represents the scan rate) are then 
plotted (figure 4.5b) and the intercept values with the y-axis give the desired value of <AH>rev 
at a given temperature. Deriving the <AH>rev profile with respect to temperature, the <AH>rev 
profile at infinite scanning rate is obtained and is shown in figure 4.6. This plot is sigmoidal, 
the midpoint of the transition representing the theoretical Tm of the transition at infinite 
scanning rate is 52.0 ±1 °C and the y-axis value at which the curve plateau’s represents the
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enthalpy of the theoretical, reversible unfolding transition, in this case a value of 958 ±8% 
Umol'1 (= 229 ±2% kcal mol"1).
It is possible to establish the path of the folding-unfolding transition in simple terms 
using a mechanical-statistical analysis of the thermodynamic Cp exc profile, obtained from the 
first derivative of <AH>rev, with respect to temperature (La Rosa et al., 1995). The Cp exc 
profile for Campath-IH is shown in figure 4.7. It is clear that the curve comprises at least 
two components and if we treat this curve as though it was an experimental DSC profile, the 
main ‘transition’ (Tm=51 °C) has AHcai= 975 ±10% kJmol"1 (233 ±3% kcal mol"1) and AHvh= 
529 ±7% kJmol"1 (126 ±2% kcal mol"1) (in this case, since the data are not experimental DSC 
data, Origin software cannot be used to calculate the calorimetric and van’t Hoff enthalpies). 
AHcai is taken to simply equal the area under the curve and AH vh is calculated using the 
equation below (Sturtevant, 1974; Privalov, 1980)):
4R T 2 < C .  >_,A „  _ --------m----------
vH A H
The ratio of these calorimetric and effective enthalpies (i.e. AHVH/AHcai) is 0.54 which 
suggests that the reversible step involves at least one significantly populated intermediate 
phase (Sturtevant, 1987).
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4.3 Discussion
By demonstrating the calorimetric irreversibility of the DSC scans of each of the 
mAbs using a successive annealing technique (Shnyrov and Mateo, 1993; Kreimer et al., 
1995; Shnyrov et al., 1996) and the fact that the Tm of the ‘main’ transition of all three mAbs 
increases on increasing the scan rate, we have shown that the denaturation process is, at least 
to some extent, kinetically controlled (Sanchez-Ruiz, 1992). In doing so we have precluded 
the interpretation of the calorimetric data in terms of equilibrium thermodynamics (Freire et 
al., 1990). Irreversible, scan rate dependent calorimetric transitions have been successfully 
analysed in terms of a two-state kinetic model originally developed by Sanchez-Ruiz et al. 
(1988a) in many examples (Sanchez-Ruiz et al., 1988b; Arriaga et al., 1992; Galisteo et al., 
1992; Galisteo and Sanchez-Ruiz, 1993; La Rosa et al., 1995; Zhadan and Shnyrov, 1994; 
Kreimer et al., 1995; Garda-Salas et al., 1996; Shnyrov et al., 1996; Vogl et al., 1997; 
Milardi et al., 1998; Davoodi et al., 1998). The model, one particular case of the Lumry and 
Eyring model (Lumry and Eyring, 1953), assumes that a calorimetric transition can be 
represented as N  —» D , where N is the native state, D the unfolded (or final) state formed 
with the first-order kinetic rate constant of k. This model has the mathematical form given in 
equations 2.15-2.17.
Analysis of the DSC traces of all three mAbs, according to the method described by 
Sanchez-Ruiz et al. (1988a) was carried out and the results presented in table 4.7. The 
validity of equations 2.15-2.17 requires the linear dependence of In k and ln[ln(0«/(GrG))] 
versus l/T  and \n(y/Tm2) versus l/Tm and that the activation energies calculated using 
equations 2.15-2.18 are all in agreement. All the plots for each of the three mAbs fulfil this 
linearity criterion (figure 4.3 is an example) but it is obvious from table 4.7 that the activation 
energies calculated using equations 2.15-2.18 differ significantly. From this we can conclude 
that the two-state irreversible model does not accurately represent the DSC data from these 
mAbs. Despite this there is some merit in this method of analysing the DSC traces of the 
mAbs as although it may not give a definite value for the activation energy, the values 
obtained from equations 2.15-2.18 are in the same region and can be used empirically to judge 
the stability of the protein. For example, we have shown in table 4.7 that the average 
activation energy for the thermal denaturation of Campath-IH increases over the pH range 3- 
5, this is in agreement with the increase in the Tm (the most empirical indication of stability) 
of the main thermal transition over this pH range. We can therefore state that Campath-IH is
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more stable in pH 5 than in pH 3 both in terms of the temperature that it will start to unfold 
and in terms of the actual amount of energy required to carry out thermal denaturation. This 
is possibly due to hydrogen ion (H+) interacting with the residues on the unfolded form of the 
protein and thus destabilising the folded form. Utilising activation energies in this manner as 
a measure of stability will be used again in chapter 5 to monitor the effects of formulation 
additives on the stability of the mAbs. It is interesting to note that the activation energy of 
366 kJ mol'1 ±15% calculated for Campath-IH (pH 3) is larger than the denaturation enthalpy 
per mole (AH= 254 kJ mol'1 ±5%) and this may suggest a transition state made up of more 
than one molecule of Campath-IH and would be consistent with a mechanism in which the 
irreversible step is preceded by the cooperative (and non-dissociative) unfolding of a dimer (or 
other aggregate) (Galisteo and Sanchez-Ruiz, 1993). A similar difference in activation energy 
and denaturation enthalpy is observed for all the mAb transitions studied.
Calculation of the activation energy of a two-state kinetic process using equation 2.15 
requires the calculation of the first-order rate constant at a range of temperatures and these 
rate constants are easily converted to half-lives. We have calculated the half-life of Campath- 
IH (pH 3) at 20 °C to be 615 days which is a realistic value but on increasing the pH to 4 and 
then 5 yields half-life predictions of 7 .5xl07 and 3 .0xl012 days respectively. These values at 
pH 4 and 5 are clearly unrealistic (1012 days is a literally astronomical number) for a protein 
which has a pharmaceutical shelf-life of two years and suggests the system is more complex 
than can be represented by a simple two-state model (the complexity of the unfolding has 
already been indicated by the AH^/AHc^ ratios for the DSC transitions presented in tables 
4.1-4.5. Consistently AHVH<AHcaj which, in the case of reversible systems, usually reflects a 
breakdown of the simple two-state model assumption, indicating that the unfolding of 
Campath-IH involves several steps with at least one significantly populated intermediate 
phase (Sturtevant, 1987)). Although this model is indeed simple, other more complex models 
may come back to a first-order kinetic process (Sanchez-Ruiz et al., 1988a). For instance, a 
more realistic representation of the irreversible thermal denaturation of these mAbs might be 
(Lumry and Eyring, 1954)
N ~ ix~*D— ^—>7 
*2
where /  is a final state irreversibly arrived at from the unfolded state, D. This model still 
applies even if the reversible unfolding step involves one or more significantly populated
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intermediate states (Freire et al., 1990; Sanchez-Ruiz, 1992). If it assumed that all three 
processes are first-order and that k3» k 2 at any moment, most of the D  molecules will be 
converted to I rather than returning to N  through the process D-+N. As a result the 
equilibrium between N  and D  will not be established as the concentration of D  will always be 
low and the denaturation may be considered as an irreversible process, A—>/, kinetically 
controlled by the rate-determining N  to D  conversion step, i.e. N  — ^—»I , which leads to the 
same kinetic equations describing the original model N—>D (Sanchez-Ruiz et al., 1988a). 
This leads to the question of how to devise a model of suitable complexity to represent mAb 
thermal unfolding which cannot be simplified to this same original model. It must be made 
clear at this stage that any model devised with the purpose of half-life predictions should take 
into account denaturation processes other than thermal unfolding which affect the mAbs. For 
example, Campath-IH is known to be subject to acid cleavage and copper ion (Cu2+) induced 
cleavage in addition to the more universal oxidative processes which affect proteins. It is 
these processes rather than thermal unfolding which are likely to dictate the half-life of a mAb 
at ambient temperatures. It is possible therefore that the half-lives calculated for Campath- 
IH (pH 3, 20 °C) are accurate but are relevant only if thermal unfolding is the single process 
leading to denaturation of the mAb.
DSC data pertaining to the denaturation of Campath-IH at pH 3 was successfully 
extrapolated to infinite scanning rate using in an attempt to separate the reversible and 
irreversible steps of the denaturation process (Freire et al., 1990; La Rosa et al., 1995; 
Milardi et al., 1998). This analysis yielded information pertinent only to the species that are 
in thermodynamic equilibrium and a Tm of 52 ±1 °C (comparable to the experimental Tm 
observed at a scan rate of 72.3 °C/hr reported in table 4.1) was calculated for the reversible 
transition with a corresponding AH of 229±2% kcal mol'1. Analysis of the time independent 
Cp exc profile (obtained from the first derivative of <AH>rev, with respect to temperature) 
allowed the calculation of a AHcai of 233 ±3% kcal mol'1 and a AHvh of 126 ±2% kcal mol'1, 
leading to a AHVH/AHca] value of 0.54 which again suggests that the reversible step involves at 
least one significantly populated intermediate phase (Sturtevant, 1987). Note: where 
AHvh/AHcai >1, no explanation can be given but such a result suggests that the cooperative 
unit consists of more than one molecule.
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Scan Rate 
/°C h r 1
Tm
/°C
AHcai
/kcal mol*1
AHvH 
/kcal mol*1
AHvn/AHca,
10.7 47.4 ±0.04 307 ±4 126 ±2 0.41 ±0.03
17.9 48.7 ±0.02 266 ±2 138 ±1 0.52 ±0.01
26.8 49.7 ±0.02 209 ±2 153 ±2 0.73 ±0.02
39.8 50.8 ±0.02 208 ±2 154 ±2 0.74 ±0.02
51.0 51.2 ±0.02 249 ±2 146 ±2 0.58 ±0.02
72.3 52.5 ±0.01 286 ±1 131 ±1 0.46 ±0.01
Table 4.1: Curve fitting data for Campath-IH (pH 3 CBS). Data are fitted to one non-two 
state curve, all data are scan rate and concentration normalised. AHcai and AH vh denote the 
apparent calorimetric and van’t Hoff enthalpies respectively.
78
Sc
an
 
R
at
e 
T
m
l 
A
H
ca
n 
A
H
vh
i 
A
H
vh 
1/
A
H
ca
i 1
 
T
m2 
A
H
ca
i 2
 
A
H
vh
2 
A
H
vh 
2)
A
H
ca
i
Chapter 4
©
S
1
0B
1
©B
1
0  
E
1
O
04
©
04
©
04
©
CO
©
04
©
S S s
00
CO
T)-
CO
O '
CO
©
""d"
VO
CO
0 © © © © ©
+1
04
+1
04
+1
04
+1
04
+1
04
+1
O
«T) 3
SO
i-H
CO
in
04
in
00
•d-l-H
CO
+1 1 i
CO
+1
m
+1 % t
m
Os
CO
OO
"•d"
CO
Os
CO
VO
OO
CO
©
O '
CO
m©
■d"
04
O
CO
©
04© CO© CO© CO©
O
+1
©
+1
©
+1
0
+1
©
+1
©
+1
OO © 00 "d" CO 00
SO
SO
00
VO
00
VO
Os
SO
©r- ©O '
OO 04 COy^H OS m1—H ■d-i S % i S i
m
00
CO
04
CO 0 -
04
04
04
in
CO
CO oi 04 04*
139
 
±1
4
10
1 
±7
120
 
±9
13
1 
±1
3
127
 
±1
0
104
 
±8
CO
+1 ? i
CO
+1
in
+1
-d-
+1
in
+1
SO
CO
04
00
VOm o-m O 'in o*r-
0 4 04 04 04 04 04
©
+1
©
+1
©
+1
©
+1
©
+1
©
+1
VO 00 Os CO in
©
vn
©
in m
©
m in in
o* © SO ■d- Os in
©l-H 00 SO04 OsCO ©in oi
* 8C/5
73
o
G
G
0
1 
SoGOo
T3
<D4->
I
cd
cdT3
Id
of<u
o
2
BC/5
0
£+->1
§
G
O
£
T3
<DtsIS
I
cd
cd
Q
co
2
C/5
©
* £ .
■S
§
d
o
ffi
ffi
> 3
i
U
cd
"cd
T )
W)
.stss
o
£
G
u
>
*o
%
o
B
§•c
o
13
o
•4—4
§
CL,
9*
©
©4->
o
G
<U
T3
X
<1 T3 
T f G
S J
5  5
79
Sc
an
 
Ra
te 
T
ml 
A
H
cai 
i 
A
H
vh
i 
A
H
VH
i/A
H
can 
T
m2 
A
H
cai
2 
A
H
vh
2 
A
H
vh 
A
H
cai 
2
Chapter 4
©
H
1
0 
£
1
iS
0 
S
1
oB
!
J-i
43
VO m VOO 0 0
S s S
VO 'd- r-CO m
0 d d
so CO VO+1 +1 +l
m vo 0000 O CO(N CN
c o
+1
voo
in
+1
O nVO
+1
00
tJ-
VO <N CO0 O 0
0 O 0+1 +1 +1
vq
CO inr- t-"
Os 00O O
1 S S/ r-H COCO 1-H
+1
r-
(N+1
O n
in
o s
+
<Nm<N
o+1
vq
>nVO
<N+1
Os
in
co
o+1
o
OsVO
VO 00 in
0 VO1-H 1—H CN
*8C/3 • ^
13
0 c
PS
1
!coo
I1-4
8
I
cd
cd
T3
T3
tld
§
cd
cd
Q
CO
«
U
in
fficl
■Stsd
0)
t©
U
n
3cs
H
c
§a*
&
©
ao
8
TD
O
W)
Id
T3
a
§>
CL,
43O
3
£
<D-<_i
<D
•8
w  . a  .>
cdCL
U
cd
Oc
*§>
43
cd
*8
43
ocd 
T3
b0 UCO
Q
©
43
cd
43
IO
-3
.S
o0)
CL
O• CL
13
3
(3
©
do
ffi
>
T3
•4—»
Ido
13o
80
Sc
an
 
R
at
e 
T
m2 
A
H
ca
i 2
 
A
H
vh 
2 
A
H
vh 
2/A
H
ca
] 2
 
T
m3 
A
H
^i
 3
 
A
H
vh 
3 
A
H
vh 
3/A
H
ca
i
Chapter 4
S
1
0 
E
1
0 
E
1
U
InA
Ov vo 1-H OO
O i—1 ©
O © CO © O ©
+1 +1 +1 +1 +1 +1
CO tJ- m ©
Ov Ov CO © ©
O CN CS cs* 1-H t—4
in+1
CO
CS
%
VO
(N
+1
vo +1
S  s  2
+1
ov
Tfr CO
+1 +1 +1
VO COin vo VO
CS cs
+1 +1 +1
Ov m Ov
CS cs
<S cs CS
vo+1
ino
in+1
00+1
vovo
CS
m
+1
■'fr
+1
1-H 1-H cs cs
© © <d cd cd ©
+1 +1 +1 +1 +1 +1
Ov CO OV vq cs
in v d Ov cdm m m in m vo
CO 00 00 m cs
© © © © ©
c5 cd cd cd cd cd
+l +1 +l +l +l +l
cs 00 © CO vot - © Ov 00 VO
© © cd cd
Ov r - m CS
+1 +1 +1 +1 +1 +1
0 in r - VO cs Ov
tj- CO cs OVcs cs cs cs cs
CO
+1
CO
o
CO
cs cs cs cs cs cs
© © © © © ©
© cd © © cd cd
+1 +1 +1 +1 +1 +1
00 cs t"; ©
in vd 00 00
tj-
00 cs cs vo OV
cd 00 vd Ov ©
1-H cs CO in r -
■8c/a
3^
o
g
g
0
1  
G
CDoGo
CD
I
IT3
81
Chapter 4
Scan Rate Tm AHcai AHvH AHvH/AHca,
f° C h r 1 /°C /kcal mol'1 /kcal mol’1
10.8 58.0 ±0.05 569 ±14 160 ±5 0.28 ±0.06
18.0 58.7 ±0.09 447 ±21 180 ±9 0.40 ±0.09
26.1 59.4 ±0.25 412 ±42 159 ±20 0.39 ±0.23
Table 4.5: Curve fitting data for 1209W95 (pH 6.6 ABS). Data are fitted to one non-two 
state curve, all data are scan rate and concentration normalised. AHcai and AHvh denote the
apparent calorimetric and van’t Hoff enthalpies respectively.
Concentration Tm AHcai AHvh
/mM /°C /kcal mol'1 /kcal mol’1
0.018 50.8 ±0.04 49 ±3 153 ±8
0.007 50.7 ±0.02 51 ±3 153 ±7
0.004 50.5 ±0.09 88 ±8 135 ±14
Table 4.6: Concentration dependence. Curve fitting data for first endotherm of Campath-IH 
(pH 6 CBS) scanned at a nominal scan rate of 60 °C/hr showing thermodymic parameters are 
independent of concentration. Data are fitted to one non-two state curve, all data are scan rate 
and concentration normalised. AHcai and AHvh denote the apparent calorimetric and van’t 
Hoff enthalpies respectively.
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Figure 4.1: Effect of scan rate on the DSC trace of Campath-IH (pH 3 CBS). Graph shows 
raw data produced on scanning at six different scan rates: (a) 10.7, (b) 17.9, (c) 26.8, (d) 
39.8, (e) 51.0 and (f) 72.3 °C/hr. Buffer baselines have been subtracted and scans are y- 
offset for clarity.
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Figure 4.2: Effect of concentration on the thermal unfolding of Campath-IH (pH 6 CBS). 
All scans were performed at a scan rate of 39.8 °C/hr using protein concentrations in the 
range 0.001 mM to 0.026 mM. The graph shows data after baseline subtraction and 
concentration normalization. Scans are y-offset for clarity.
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Figure 4.3: Plots corresponding to equations 2.15-2.17 for Campath-IH (pH 3 CBS), (a): 
Arrhenius plot. ■, k values calculated from equation 2.15 for each of the six scan rates used, 
(b): Plot of In (v/Tm2) versus 1/Tm. Here the 1/T coordinate represents 1/Tm. Each data point 
corresponds to one of the six scan rates used, (c): Values of In [lnQ/(Q-Qt)] plotted versus 
1/T. Each set of symbols represents a different scan rate: □, 10.7, +, 17.9, A, 26.8, ■, 39.8,
0 ,5 1 .0  and • ,  72.3 °C/hr.
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Figure 4.4: Plot of extrapolated half life (in days) versus pH for Campath-IH at 20 °C. The 
graph is plotted as a logarithmic plot. Each data point represents the half life calculated at a 
particular pH
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Figure 4.5a: Plot of the cumulative enthalpies, <AH>, calculated for Campath-IH (pH 3 
CBS), at six different scan rates as a function of temperature.<AH> is calculated using 
equation 2.19 in accordance with the method described by La Rosa et al., (1995) and Milardi 
et al., (1998). Each data point represents the thermodynamic cumulative enthalpy over all the 
temperatures within the denaturation range.
Chapter 4
I i ■ i 1 i ■ i 1 i 1 i  1 r
uo Uo uo uo Uo Uo uo uo Uo Uo Uo Uo p Uo Uo
o CN c o
-r t
VO
M-
r-~ OO ON O c s
m
r o
t o
Tj-
•O
■ □ • O < < ► > ♦ o + X 0 □ O
B o  X +  O  4  >  4  <  4  o  « c a
-  in
OQ o x ► <J 4 CO
40 0
O d
♦ > MO
o ♦ t>*»
O ♦  >Mi
+ O ♦ OfrO
O
O
CNi
T
ooo
oo
oo
T
oo
CD
O
O
oo
CVJ
T
o
— Tf
p
- oo
-  CM
( join F[) <HV>
Figure 4.5b: Exponential plots of the cumulative enthalpies of denaturation <AH> versus 1/v 
(v represents the scan rate) obtained at a range of temperatures over the entire denaturation 
range (40-54 °C). The intercept values with the y-axis give the desired value of <AH>rev at a 
given temperature (<AH>rcv represents the cumulative enthalpy function containing 
information pertinent only to the species in thermodynamic equilibrium as described by La 
Rosa et al., (1995)).
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Figure 4.6: Plot of <AH>rev with respect to temperature for Campath-IH (pH 3 CBS). 
<AH>rev represents the cumulative enthalpy function containing the information pertinent only 
to the species that are in thermodynamic equilibrium. The data plotted represents the 
thermodynamic cumulative enthalpy of the denaturation process extrapolated at infinite 
scanning rate. The midpoint of the sigmoidal plot, 52.0 ±1 °C, represents the Tm of the 
transition at infinite scanning rate, and its maximum of 958 ±8% kJmol'1 (229 ±2% kcal 
mol'1) represents the enthalpy of the transition.
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Figure 4.7: C pexc profile of Campath-IH (pH 3 CBS) at infinite scanning rate obtained from 
the first derivative of <AH>rev with respect to temperature (dashed line). The solid line 
represents best fit curve of the data using Origin software and represents a transition with a 
Tm of 51 °C and a calorimetric enthalpy of 975 +10% kJmol'1 (233 ±3% kcal mol'1).
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CHAPTER 5
FORMULATION AND THE EFFECT OF ADDITIVES AND
ADJUVANTS
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5.1 Introduction
When studying any aspect of a protein, one of the most important considerations is 
the formulation of that protein. If the species under investigation is lyophilized, it may 
contain cryoprotectants e.g. sucrose or dextran (Chang et al., 1993), buffer salts or other 
additives. When dealing with proteins in solution, the picture becomes somewhat more 
complex with the consideration of pH, buffer components, ionic strength, protein 
concentration, preservatives, and when studying proteins of pharmaceutical interest further 
complexity is introduced when toxicity and suitability for parenteral dosage must be 
determined (Wang and Hanson, 1988; Manning et al., 1989).
Solution pH plays a critical role in the stability of a protein or peptide and proper 
selection of pH may be considered as the key to a successful formulation. A basic rule of 
thumb is to identify the pH at which overall degradation reactions are minimal. Many 
peptides are formulated at a slightly acidic pH: the pH of oxytocin injection (9 amino acid 
peptide, Mol. Wt. 1007) is in the range of 2.5-4.5; that of desmopressin injection is 3.5; and 
nafrelin is most stable at pH 5 (Johnson et al., 1986). At low pH, degradation reactions 
include the deamidation of asparagine and glutamine and the general hydrolysis of the peptide 
backbone and glycosides; whereas at high pH, oxidation of cysteine, transpeptidation of 
aspartic and glutamic acids, deamidation of asparagine and glutamine, and the racemization 
of amino acids with an electron withdrawing side chain, e.g. proline, are potential degradation 
mechanisms. In the case of more complex proteins where the stabilization of the native 
conformation (necessary for bioactivity) is the main concern, the pH is often set at the 
isoelectric point (point at which the net charge on the protein is zero) presumably to maximise 
interactions between salt bridges and reduce interactions between neighbouring protein 
molecules (Wang and Hanson, 1988). In a pharmaceutical context, the pH of globulin 
products (i.e. antibodies and related proteins) is close to neutrality; 7.4 for Orthoclone OKT® 
3 and 6.6 for Sandoglobulin®. However an exception to this is the immunoglobulin 
Gamimune® N, which for reasons of stability, is formulated at pH 4.25 for intravenous use 
(Tenold, 1983).
Campath-IH in addition to other IgG molecules is sensitive to acidic conditions. 
Cleavage occurs at the acid labile Asp-Pro bond at residues 274-275 in the heavy chain at pH 
3 (Wellcome Company Document No: BZGA/91/0018, 1992, private communication). The
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acid degradation of Asp-Pro peptides is well documented (Landon, 1977; Inglis, 1983). The 
results of acid induced cleavage of Campath-IH, and indeed other IgG molecules can be 
examined by reducing SDS-PAGE (Laemmli, 1970). To avoid complications caused by acid 
induced cleavage, Campath-IH was only studied in acidic pH when absolutely necessary (in 
reality for most experiments) and care was taken to ensure that samples were freshly prepared 
and stored cold.
In this thesis, the effect of pH, additives such as L-histidine and n-methylacetamide 
(known as osmolytes), sugars (mannitol and lactitol), cyclodextrins (methyl-p-cyclodextrin 
and hydroxypropyl-p-cyclodextrin), surfactants (Poloxamer 188 (Pluronic F68) and 
polysorbate 80), and polyelectrolytes (DEAE-dextran), and combinations of the above on the 
thermal stability of all three mAbs has been studied both in the short term and, in the case of 
Campath-IH and 1209W95, long-term (2 years at 4 °C in formulation containing additive(s)). 
The long-term effects of additives on 4162W94 has not been studied as its stability is thought 
to be comparable to Campath-IH which we consider to be a stable model mAb. The effect of 
these additives has been determined using a combination of biophysical techniques namely 
DSC and fluorescence spectroscopy (both fluorescence quenching experiments and the use of 
the extrinsic fluorescent probe ANS).
DSC has been used in previous studies as a means of conveniently and qualitatively 
studying the effects of a wide range of additives (Ahmad and Bigelow, 1986; Chang et al., 
1993; Gombotz et al., 1994; Pico, 1996; Fatouros et al., 1997a; 1997b; Giancola et al., 1997; 
Remmele et al., 1998) by observing any changes in the Tm of unfolding, that is the peak 
maximum of the denaturation endotherm, on the basis that an additive expected to stabilise 
protein should increase the Tm while a destabilizing additive should decrease the Tm. 
Presented in this chapter, in addition to additive induced changes in Tm, are the effects of 
cyclodextrins on the activation energies of denaturation calculated by the method reported by 
Sanchez-Ruiz et al., (1988a). Fluorescence too has been used previously to assess the 
formulation of proteins. Busby and Ingham (1984) used ANS to probe the effect of various 
sugar compounds on the thermal stability of antithrombin HI and this method, in addition to 
fluorescence quenching, is useful when studying the structural effects of pH.
In many instances the mechanisms by which additives exert their effects have been the 
subject of much work. The stabilising effects of neutral salts has been explained by Ahmad
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and Bigelow (1986) and Pico (1996) as a combination of several factors including the 
strengthening of hydrophobic interactions within the protein, and the effects are often 
discussed in terms of the preferential interactions between the protein and solutes (Timasheff 
and Arakawa, 1989). Polyalcohol materials such as mannitol and other sugars are well 
known to stabilize proteins with respect to denaturation through selective solvation of the 
protein (Lee and Timasheff, 1981), that is, at low additive concentrations, more water 
molecules pack around the protein in order to exclude the additive.
Many organisms which have adapted to environmental stress such as high 
temperatures or desiccation accumulate low concentrations of low molecular weight 
compounds called osmolytes which are believed to confer protection to enzyme and other 
macromolecular systems against such denaturing stresses (Lin and Timasheff, 1994). These 
osmolytes can include urea, amino acids, methylamines and sugars. For the purpose of this 
thesis we have taken L-histidine and n-methylacetamide as representative osmolytes. 
Osmolytes in general are thought exert their stabilizing effect through selective solvation of 
the protein in a similar manner to the mechanism described above for polyalcohol materials 
(Santoro et al., 1992; Plaza del Pino and Sanchez-Ruiz, 1995).
Cyclodextrins and their effects on proteins are probably the least studied though 
probably best understood of the additives which were chosen for study in this thesis. They are 
cyclic oligomers of glucose produced by the enzymatic degradation of starch by cyclodextrin 
transglycosylase (CTG) and are classified by the number of a-l,4-linked glucose units which 
comprise their structure, a-cyclodextrin has six such units, p-cyclodextrin has seven and y- 
cyclodextrin, eight. The molecules themselves are toroidal in shape comprising a hydrophilic 
outer surface with an apolar cavity which in the case of p-cyclodextrin has a diameter of 6.0- 
6.5 A (Li and Purdy, 1992). This cavity allows the cyclodextrins to form inclusion complexes 
with small nonpolar molecules and therefore bind to exposed aromatic groups on unfolded 
proteins (Cooper, 1992; Cooper, 1996). For the purpose of this thesis, the cyclodextrins 
studied were methyl-p-cyclodextrin (MCD) and hydroxypropyl-p-cyclodextrin (HPCD) which 
in actual fact are not true cyclodextrins but cyclodextrin derivatives which have been created 
from P-cyclodextrin to improve its solubility. Only P-cyclodextrin derivatives were studied as 
p-cyclodextrin represents at least 95% of all produced and consumed cyclodextrins and hence 
benefits from low cost and wide availability. The potential use of cyclodextrins in parenteral 
formulations has been reviewed by Brewster et al., (1989) with HPCD emerging as the most
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promising due to its high solubility and low intravenous toxicity (Brewster et al., 1990) and 
its ability to increase the solubility and stability of several protein drugs (Brewster et al., 
1991; Szejtli, 1991).
The surfactants Poloxamer 188 and polysorbate 80 have been chosen as additives to 
study as they are both surfactants which are available for use in the parenteral formulation of 
drugs. Orthoclone OKT® 3, a therapeutic mAb approved by the Federal Dmgs 
Administration (FDA) formulated with 0.02% polysorbate 80 as a stabilizer, is just one 
example. Surfactants have the ability to cause denaturation of protein both by charge group 
separation and hydrophobic disruption and therefore for the purpose of drug formulation they 
are used at extremely low concentrations (<0.04%). At these low concentrations they are able 
to prevent denaturation of proteins at air/liquid or liquid/liquid interfaces. Protein has a 
tendency to denature at these interfaces due to the fact that their combination of polar and 
nonpolar side chains creates a tendency for them to concentrate at these interfaces. Once the 
protein has concentrated at the interface, a monolayer of protein can form at the surface of the 
protein solution which will not dissolve due to irreversible unfolding when the surface area is 
increased (Adamson, 1960; MacRitchie, 1978). The addition of surfactant reduces this 
problem by reducing the interfacial tension and therefore reducing the propensity for 
unfolding or by solubilizing the protein to reduce the amount of protein at the interface. If, 
even at low concentrations surfactants cause some degree of denaturation, it should be noted 
that for an injectable formula, surfactant concentration can be greatly reduced by dilution in 
intravenous bags prior to injection.
Inspired by data presented at The First International Conference on Protein 
Stabilization (Leeds, U.K., 28 June-1 July 1998) by Dr T. Gibson (Applied Enzyme 
Technology (Ltd.) which suggested that protein stability may be increased by a combination 
of low concentrations of DEAE-dextran (polyelectrolyte) and lactitol (polyalcohol), the effect 
of these additives on Campath-IH has been investigated. This chapter contains details of how 
these additives affect both the calorimetric reversibility of unfolding and the Tm of the main 
transition. Dr T. Gibson has proposed that the DEAE-dextran bound to protein surface 
charges to form a cage-like structure which protected and supported the native form of the 
protein (no relevant publications are available at time of writing).
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5.2 Results
5.2.1 Determination of Optimal pH
The effect of pH on the DSC scans of the three mAbs has been discussed in chapter 3 
with the effect of pH on Tm presented in tables 3.1, 3.2 and 3.3 for Campath-IH, 4162W94 
and 1209W95 respectively. With a view to studying long-term stability and the effect of 
additives on the mAbs, the pH and buffer type which resulted in the highest Tm and therefore 
greatest thermal stability was chosen. For Campath-IH and 4162W94 pH 6 CBS was 
selected and pH 8 TBS was selected for 1209W95.
The effect of pH on the structure of the mAbs was also studied using fluorescence 
quenching techniques to probe the accessibility of the tryptophan residues within each of the 
proteins. Succinimide quenching of Campath-IH was carried out at pH 3.5, 4, 5, 6 and 7.4. 
All results were corrected for buffer effects and dilution of protein sample on addition of 
aliquots of quencher (a 2.5 M solution of succinimide was used throughout) and plotted as 
Stem-Volmer plots as described in chapter 2: Materials and Methods. The gradient of the 
line, Ksv (the Stem-Volmer constant) was then calculated using Origin software and used as a 
measure of the accessibility and hence compactness of the protein structure, with a large Ksv 
indicating greater tryptophan accessibility (and hence less compactness of structure) and a 
smaller Ksv indicating the opposite (Eftink and Ghiron, 1976a; 1976b; 1984). The Stem- 
Volmer plot obtained on quenching Campath-IH (pH 6 CBS) with succinimide is shown in 
figure 5.1 as an example of the high quality of results obtained (inset plot shows slight 
negative deviation of line). KsV values for Campath-IH, 4162W94 and 1209W95 obtained 
under other pH conditions are presented in table 5.1. Succinimide quenching studies were 
also carried out on samples of Campath-IH (pH 4 ABS) which had been scanned at 10 °C/hr 
to 100 °C. These samples had not visibly aggregated during the scan but quenching gave a 
Ksv of 4.1 ±0.5 M'1 (compared to a pre-scan value of 0.7 ±0.2 M'1) which is indicative of 
increased tryptophan exposure conducive to unfolding.
The quenching data plotted in the inset plot of figure 5.1 are identical to the data 
presented in the main plot but the scale is chosen to illustrate the fact that what appears to be 
a linear relationship in the main plot, has in fact a slight negative deviation, that is, a 
downward curve. Similar quenching patterns have been observed by Lehrer (1971), and
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Teale and Badley (1970) and are the result of the ability of certain tryptophans in a protein to 
be selectively quenched before others (Eftink and Ghiron, 1976a). It is an effect only 
observed for multi-tryptophan proteins. At a low concentration of quencher, the slope of the 
Stem-Volmer plot reflects the quenching of the more accessible residue(s) whereas at higher 
quencher concentrations, the tryptophans having lower quenching constants become dominant 
as the easily quenched fluorescence has become greatly depleted. This type of selective 
quenching can only be detected if the quenching constants for each fraction of the fluorescence 
are quite different as if they do not differ sufficiently the results are apparently linear plots.
In an attempt to compliment the data obtained from quenching experiments it was 
decided to move from succinimide quenching to acrylamide quenching. Acrylamide is a small 
organic uncharged quenching probe that is very sensitive to the degree of exposure of 
tryptophans in proteins (Eftink and Ghiron, 1976a). It also quenches with a larger rate 
constant than succinimide (Eftink and Ghiron, 1984). It was hoped that using acrylamide as a 
quencher would produce more significant differences in Ksv on changing the pH conditions of 
the proteins. The results from a typical acrylamide quenching experiment are shown in figure 
5.2a. This figure shows the data obtained by quenching Campath-IH (pH 6 CBS) with 
acrylamide in comparison to the quenching of a solution of free L-tryptophan in pH 6 CBS. 
Both data sets are plotted as Stem-Volmer plots. In this plot there is an obvious upward 
curve of the free tryptophan quenching data and in fact there is a slight upward curve of the 
Campath-IH data too. This upwards curvature is a result of static quenching and occurs as a 
result of the quenching reaction produced by acrylamide and other efficient quenchers where 
there is a high probability of quencher and chromophore molecules being near in space at the 
moment the latter is excited. In such a case the probability of the reaction occurring is so high 
that quenching occurs almost instantaneously (statically) (Eftink and Ghiron, 1976b). Static 
quenching can be taken into account by plotting the data as a modified Stem-Volmer plot as 
described in Chapter 2. Figure 5.2b shows a modified Stem-Volmer plot for Campath-IH 
(pH 6 CBS) in comparison to the quenching of a solution of free L-tryptophan in identical 
buffer. Both datasets produce linear plots. The Ksv values obtained by acrylamide quenching 
and subsequent modified Stem-Volmer analysis for Campath-IH, pH 3.5, 5, 6, and 7.4 are 
presented in table 5.1. It is evident that there are no benefits to be had in using acrylamide as 
quencher as there is no real gain to be made in distinguishing the degree of accessibility of 
tryptophan exposure in each of the pH conditions tested. This and the fact that acrylamide is 
extremely toxic and the data obtained from quenching experiments must be corrected for
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static quenching and the absorbance of acrylamide itself precluded further acrylamide 
quenching studies.
As mentioned previously, IgG molecules are prone to acid cleavage. In the case of 
Campath-IH it is the Asp-Pro bond at residues 274-275 on the heavy chain which is acid 
labile (Wellcome Foundation Document No: BZGA/91/0081, private communication) and 
cleavage at this site results in fragments of approximately 30 and 20 kDa. This cleavage 
pattern can be seen using reducing SDS-PAGE and the results are shown in figure 5.3. Lanes 
1 and 6 are molecular weight standards (comprising phosphorylase b, bovine semm albumin, 
ovalbumin, carbonic anhydrase, soybean trypsin inhibitor and a-lactalbumin), lanes 2 and 3 
are Campath-IH (pH 7.2 PBS) and lanes 4 and 5 are Campath-IH which has been dialysed 
into pH 3 CBS and stored for 13 days. Due to the reducing conditions, the molecule has been 
cleaved into its light and heavy chains (bands at 50 and 25 kDa) and acid cleavage has 
produced two further bands at approx. 30 and 23 kDa. To minimise this cleavage stability 
studies were carried out at pH 6 and care was taken to keep samples refrigerated at all times.
5.2.2 Short and Long-term Effect of Additives
Using a core set of nine additives/additive combinations comprising the following: 5% 
and 10% (w/w) mannitol, 0.01% (w/w) Poloxamer 188, 100 mM n-methylacetamide, 3% 
(w/w) L-histidine, 3% (w/w) L-histidine + 0.01% (w/w) Poloxamer 188, 100 mM methyl-p- 
cyclodextrin, 100 mM hydroxypropyl-P-cyclodextrin, and 3% (w/w) L-histidine + 100 mM 
methyl-p-cyclodextrin, the effects on the three mAbs Campath-IH, 4162W94 and 1209W95 
were studied using DSC, fluorescence quenching techniques, visual inspection and ANS 
binding. Samples were studied both immediately after formulation with the additive(s) and 
also after two years at 4 °C. For the long-term studies, a sample of mAb in relevant buffer 
without any additives which was filled into vials, stoppered, and sealed at the same time and 
under the same conditions as the samples with additives, was used as the control.
All formulations were scanned in the DSC at a scan rate of 60 °C/hr, using identical 
buffer + additive in the reference cell. Each sample was subjected to two scans to check for 
calorimetric reversibility- none of the formulations of any of the three mAbs showed any 
reversibility. The DSC data was then concentration normalized, baseline subtracted and the
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Tm of the main transition recorded. The short-term effects of additives on the Tms of 
Campath-IH (pH 6 CBS), 4162W94 (pH 6 CBS) and 1209W95 (pH 8 TBS) are presented in 
table 5.2 as the change in Tm with respect to the control values of 78.2 °C, 77.1 °C and 61.3 
°C for Campath-IH, 4162W94 and 1209W95 respectively. In a similar fashion, the results 
of the long-term effects of additives on Campath-IH and 1209W95, with respect to a control 
samples stored under identical conditions, are presented in table 5.3. Visual inspection 
revealed that all vials contained a clear bright solution. It is immediately clear from tables 5.2 
and 5.3 that cyclodextrins have a strong destabilising influence on the proteins.
To monitor whether the additives affect the accessibility of the tryptophan molecules 
(i.e. affect the compactness of the structure), fluorescence quenching studies using 
succinimide as quencher were carried on long-term storage samples. The results of these 
studies, tabulated as Ksv values for each formulation, for both Campath-IH and 1209W95, 
are presented in table 5.4. Prior to every fluorescence experiment, the fluorescence spectrum 
of the buffer/additive system was recorded so that it may be subtracted from the 
protein/buffer/additive spectrum to leave only the protein spectrum for analysis. Significant 
fluorescence was observed with buffer/cyclodextrin samples on excitation at 295 nm. With 
control experiments we were able to show that this fluorescence could be quenched on 
addition of aliquots of succinimide (data not shown) and therefore the data presented in table 
5.4 regarding the Ksv values obtained on quenching protein/buffer/cyclodextrin is invalid in 
the context of the other results as the data represents the quenching of both protein and 
cyclodextrin fluorescence. It has since been shown by colleagues that the fluorescence is due 
to impurities and not the cyclodextrin itself and the fluorescence can be reduced by agitating 
the cyclodextrin with activated charcoal prior to use. This fluorescence did not occur using 
an excitation wavelength of 390 nm which is the wavelength used to excite ANS and therefore 
ANS binding experiments using protein/buffer/cyclodextrin are valid.
The long-term effects of the additives on the hydrophobicity of the mAbs was studied 
by monitoring the binding of ANS to each and again comparing the results with those gained 
from control experiments. All experiments were performed at 25 °C and involved the addition 
of protein to a cuvet containing a 20 |iM solution of ANS in the relevant buffer/additive. 
Final protein concentration was 0.2 |iM. The excitation wavelength used was 390 nm and the 
emission spectrum was recorded from 400-700 nm. The wavelength of the emission 
maximum and the fluorescence intensity at this wavelength is recorded in table 5.5 for
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Campath-IH (pH 6) and 1209W95 (pH 8) formulated in the core set of additives and stored 
for 2 years at 4 °C. The table also contains the data from control experiments which involved 
monitoring ANS binding to samples of mAb in either pH 6 CBS for Campath-IH or pH 8 
TBS for 1209W95 which had been stored under identical conditions to the samples containing 
additives. The data contained in table 5.5 shows that the addition of 5 and 10% (w/w) 
mannitol, and 3% (w/w) L-histidine has no effect on the hydrophobicity of the protein surface 
over the testing period when compared to the control. Both the addition of 0.01% (w/w) 
Poloxamer 188 and the combination of 0.01% (w/w) Poloxamer 188 and 3% (w/w) L- 
histidine increase hydrophobicity slightly with a greater increase being observed on the 
addition of 0.01% (w/w) Poloxamer only. Both 100 mM n-methylacetamide and any 
formulations containing 100 mM cyclodextrin apparently greatly increase the hydrophobicity 
of the proteins over the two year period, but in fact it is the case that with cyclodextrins the 
results are void as the majority of the blue shift in ANS fluorescence is due to the ANS 
binding to the hydrophobic core of the cyclodextrins and not the proteins. So, in terms of 
their effect on hydrophobicity, we can order the additives as follows starting with that which 
shows the greatest effect: 100 mM n-methylacetamide>0.01% (w/w) Poloxamer 188>3% 
(w/w) L-histidine + 0.01% (w/w) Poloxamer 188>3% (w/w) L-histidine>5%, 10% (w/w) 
mannitol. It is not possible to include the cyclodextrin formulations in this list but we can see 
from tables 5.2 and 5.3 that the cyclodextrins and cyclodextrin/histidine formulations are least 
stable as analysed by the Tm obtained by DSC.
5.2.3 The Effects of Cyclodextrins
Studies of the effects of cyclodextrins on the thermal unfolding of proteins have been 
reported (Cooper, 1992; Cooper 1996). These studies focus on the ability of the 
cyclodextrins to form inclusion complexes with small nonpolar molecules and therefore bind 
to exposed aromatic groups on unfolded proteins. This aspect of cyclodextrin behaviour 
explains the results presented in tables 5.2 and 5.3 where the Tm of the mAbs is significantly 
reduced in the presence of both methyl-P-cyclodextrin and hydroxypropyl-p-cyclodextrin. 
This reduction in Tm can be attributed to the binding of cyclodextrin to the unfolded form of 
the protein and hence stabilizing this form, shifting the folded <-» unfolded equilibrium in 
favour of the unfolded form. The question then arises whether the cyclodextrins affect the 
activation barrier of thermal denaturation as calculated in Chapter 4 using the method 
described by Sanchez-Ruiz et al. (1988a). A full kinetic analysis, as described in chapter 4
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was carried out on the main endothermic transition of Campath-IH in the presence of 100 
mM methyl-p-cyclodextrin at pH 4, 5 and 6. The results, tabulated as the activation energies 
calculated using equations 2.15-2.18 are shown in table 5.6. If we compare these results with 
those in the absence of cyclodextrin (see table 4.7), it is clear that methyl-P-cyclodextrin not 
only destabilises Campath-IH in terms of Tm but it also causes an overall reduction in the 
activation energy required for thermal denaturation. Again this is most likely due to the 
destabilisation of the folded form of protein by the cyclodextrin.
The effects of cyclodextrins on the DSC trace of Campath-IH are concentration 
dependent. The effects of 0 ,15 , 20, 30 and 40% (w/w) HPCD on the DSC trace of Campath- 
IH (pH 6) are shown in figure 5.4 (15% (w/w) HPCD is equivalent to 100 mM). This figure 
shows that as HPCD concentration increases, the Tm of the first transition stays constant, the 
Tm of the second transition decreases and at >30% (w/w) HPCD a third endothermic 
transition occurs. These Tm values are presented in table 5.7. The finding that the Tm of the 
first transition is independent of cyclodextrin concentration is consistent with the 
interpretation of this transition as a small change in tertiary structure; we can see from figure 
3.10 that this tertiary structure change does not involve a great increase in the exposure of 
tryptophan residues and therefore there will be no significant binding of cyclodextrins to these 
residues. A fascinating aspect of the interaction of HPCD with Campath-IH is its apparent 
ability to prevent gross thermal aggregation. Figure 5.4 shows that at concentrations of 30 
and 40% (w/w) HPCD, the DSC traces of Campath-IH are not prematurely distorted by 
exothermic aggregation events and have a smooth posttransition baseline. In addition, when 
such samples are removed from the DSC cell, on visual inspection they are clear and bright. 
Attempts were made to probe the accessibility of the tryptophan residues within this scanned 
Campath-IH sample but all attempts failed due to the fluorescence of impurities associated 
with the cyclodextrin.
The nature of the third endothermic transition of Campath-IH (pH 6) which is present 
at HPCD concentrations of 30 and 40% (w/w) remains unknown. Scans of Campath-IH 
(0.018 mM, pH 6 CBS, 40% (w/w) HPCD) were performed at six different scan rates (10.7, 
17.9, 26.8, 39.8, 51.0 and 72.3 °C/hr) and the results are presented in figure 5.5. This figure 
illustrates not only the scan rate dependence of the main transition, that is the Tm increases 
with increasing scan rate (which has been discussed in some detail in Chapter 4), but also the 
scan rate dependence of this third transition. Scan rate dependence indicates that the process
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which results in the third DSC endotherm is under kinetic control (Sanchez-Ruiz et al., 1988a; 
Galisteo et al., 1992). A similar transition is also observed on the DSC trace of 4162W94 
(0.013 mM, pH 6 CBS, 40% (w/w) HPCD as shown in figure 5.6 where again the 
cyclodextrin prevents gross thermal aggregation as indicated by the absence of any 
exothermic events, the presence of a smooth posttransition baseline and a clear bright sample 
on removal from the DSC cell.
5.2.4 The Effects of DEAE-Dextran and Lactitol
The effect of DEAE-dextran and lactitol on the stability of Campath-IH (pH 6 CBS) 
as determined by the Tm of thermal unfolding was studied using DSC. The following 
additives were used (all quantities are % (w/w)): 0.5%, 1%, 5% DEAE-dextran, 1% DEAE- 
dextran + 1% lactitol, 1% DEAE-dextran + 5% lactitol, and 5% DEAE-dextran + 5% lactitol. 
Figure 5.7a presents raw DSC data illustrating the effect of 0.1 and 0.5% (w/w) DEAE- 
dextran on the DSC trace of Campath-IH and figure 5.7b presents raw DSC data illustrating 
the effect of various DEAE-dextran/lactitol combinations. The results presented in figure 
5.7b show that both 5% (w/w) DEAE-dextran and the combination of 5% (w/w) DEAE- 
dextran + 5% (w/w) lactitol prevent exothermic aggregation of the protein on the first heating 
cycle though postscan visual inspection of both samples reveal that aggregation occurs on 
heating a second time. Neither of these samples nor any other DEAE-dextran/lactitol 
combination improved the calorimetric reversibility of the DSC transitions. Figure 5.7a 
reveals that low concentrations (<1%  (w/w)) of DEAE-dextran have no significant effect on 
the Tm of either the first or the second endotherm but, as can be seen in figure 5.7b, at higher 
concentrations (5% (w/w)) it has a destabilizing influence which manifests itself as a lowering 
of both Tm values. Figure 5.7b reveals that lactitol has a stabilizing effect on Campath-IH 
but this effect can be cancelled out by the destabilizing effect of 5% (w/w) DEAE-dextran. 
As these additives failed to improve the calorimetric reversibility of the transitions and did not 
exert a stabilizing effect greater than that observed on addition of mannitol, no further studies 
were carried out using DEAE-dextran or lactitol.
103
Chapter 5
5.3 Discussion
DSC experiments with Campath-IH and 4162W94 have shown that mannitol has a 
stabilizing influence with respect to thermal denaturation, evidenced by increased Tm values in 
the presence of both 5 and 10% (w/w) mannitol. For example, the Tm of the main 
endothermic transition of 4162W94 increases by 1.6 and 2.5 °C on addition of 5 and 10% 
(w/w) mannitol respectively. Mannitol also had a stabilizing effect on 1209W95 but this 
effect was less pronounced. The overall stabilization effects of mannitol on the mAbs are 
consistent with those on antithrombin ID described by Busby and Ingham (1984).
PI 88 has no significant effect on the Tm values of the mAbs either in the short or 
long-term although fluorescence quenching with succinimide suggests that in the long-term it 
decreases the accessibility of tryptophan residues within Campath-IH and 1209W95. 
Formulation of Campath-IH and 1209W95 with P188 also appears to increase the 
hydrophobicity of the proteins slightly. It would be expected that P I88, since it is a 
surfactant, would have a denaturing effect on the proteins and therefore we would see a 
decreased Tm, increased Ksv values and increased hydrophobicity as it exerted its effect. The 
results are not in agreement with these expectations probably due to the low concentrations 
used (0.01%(w/w)) for the purpose of prevention of adsorption onto surfaces and denaturation 
at interfaces. Surfactants, by their mechanism of action, can prevent shear-induced 
aggregation but we have shown that they do not affect heat-induced aggregation. This 
emphasises the need to use several complementary techniques to assess the usefulness of 
formulation additives.
As expected, n-methylacetamide in protein formulation resulted in a small but 
significant decrease in Tm in both the short and long-term. This destabilisation is consistent 
with weak binding to exposed hydrogen-bonding peptide groups (Cooper and Nutley, 
unpublished). This destabilization effect is also suggested by increased hydrophobicity of the 
proteins in the presence of n-methylacetamide as shown by ANS binding experiments. L- 
histidine exerted no major effect on the stability of the proteins, only a very small general 
increase in Tm (in the order of <0.3 °C).
Cyclodextrins proved to be the most interesting additives studied. One major draw 
back was the fluorescent impurities within the cyclodextrins supplied as they were quenched
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in addition to the proteins during fluorescence quenching experiments and hence results from 
these experiments were void. Also, the ability of the hydrophobic cavity of cyclodextrins to 
bind ANS precluded studying the hydrophobicity of the proteins in formulations containing 
cyclodextrins by monitoring ANS binding. DSC experiments provided a wealth of 
information concerning the effects of cyclodextrins on the mAbs. As expected formulations 
containing either MCD or HPCD resulted in a large decrease in Tm values of the mAbs both 
in the short and long-term. This destabilization effect is due to the cyclodextrins binding to 
aromatic groups on the unfolded form of the protein and hence shifting the folded<->unfolded 
equilibrium to the right (Cooper, 1992; Cooper, 1996). It was found that MCD was more 
effective than HPCD in reducing the Tm. In addition to lowering the Tm we have shown, using 
the method of activation energy calculation devised by Sanchez-Ruiz et al., (1988a), that 
HPCD actually decreases the activation energy required for protein thermal denaturation. If 
the results in table 5.6 (activation energy of thermal denaturation of Campath-IH in presence 
of 100 mM HPCD) are compared with those in table 4.7 (activation energy of thermal 
denaturation of Campath-IH without HPCD) it is seen that there is a reduction in activation 
energy of 71 and 43 kJ/mol, in pH 4 and 5 respectively, on addition of 100 mM HPCD.
The effects of HPCD are shown to be concentration dependent. Table 5.7 illustrates 
the fact that the first DSC endotherm of the thermal denaturation of Campath-IH is 
unaffected by the presence of HPCD whereas the Tm of the second decreases consistently on 
addition of increasing concentrations of HPCD. Above 30% (w/w) HPCD, the DSC of 
Campath-IH reveals a third endotherm, the Tm of which is seen to increase on going from 30 
to 40% (w/w) HPCD. The nature of this endotherm is unknown (it is not feasible to record 
CD spectra at such high HPCD concentrations as the HPCD would mask the protein signal) 
but we have shown it to be highly scan rate dependent and therefore representative of a 
process under kinetic control. A similar endotherm appears when 4162W94 is subjected to 
the same treatment though no such effect appears with 1209W95 (data not shown).
None of the formulations tested resulted in any calorimetric reversibility of the mAbs. 
30 and 40% (w/w) HPCD, 5% (w/w) DEAE-dextran, and 5% (w/w) DEAE-dextran + 5% 
(w/w) lactitol showed ability to prevent thermal aggregation of Campath-IH and high 
concentrations of HPCD also prevented thermal aggregation of both 4162W94 and 1209W95. 
We propose the inhibition of aggregation is a direct effect of the cyclodextrin binding to the 
hydrophobic residues of the unfolded protein which are involved in gross aggregation of the
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unfolded protein as it is the influence of these hydrophobic regions of unfolded protein which 
make the protein clump together in order to hide these regions from the polar solvent. It had 
been hoped that although HPCD destabilized the proteins it would allow them to refold by 
acting as chaperone mimics, that is, in binding to hydrophobic residues and preventing 
aggregation, on cooling the protein sample the protein would be able to refold into its native 
form. As mentioned earlier, there was no evidence of chaperone mimicry as no calorimetric 
reversibility was observed, although it must be noted that experiments described in this thesis 
involve only two cyclodextrin derivatives and there are many others which may prove more 
suited to this purpose.
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pH Kg, (M'1) 
Campath-IH, 
0-0.375 M 
succinimide
KsvOVT1) 
4162W94, 
0-0.375 M 
succinimide
KsvOVT1)
1209W95, 
0-0.375 M 
succinimide
Kj, (M'1) 
Campath-IH, 
0-1.199 M 
acrylamide
3 (-) 1.5 ±0.2 (-) (-)
3.5 1.2 ±0.1 (-) (-) -0.7 ±0.1
4 0.7 ±0.2 (-) (-) (-)
5 1.6 ±0.1 0.8 ±0.2 (-) -0.6 ±0.1
6 1.1 ±0.1 1.1 ±0.1 (-) -0.6 ±0.1
6.6 (-) (-) 3.2 ±0.4 (-)
7.4 1.2 ±0.2 (-) (-) -0.5 ±0.05
8 (-) (-) 3.9 ±0.2 (-)
Table 5.1: Table showing the effect of buffer pH on the accessibility of tryptophan residues 
within the mAbs Campath-IH, 4162W94 and 1209W95, as measured by fluorescence 
quenching. Ksv represents the Stem-Volmer constant; the larger the value of this constant, the 
more accessible the tryptophan residues to quencher. The quencher used is either succinimide 
or acrylamide as indicated. (-) indicates no experiment was performed at this pH.
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ADDITIVE ATm (°C) 
Campath-IH, pH 6
ATm(°C) 
4162W94, pH 6
ATm(°C) 
1209W95, pH 8
5% (w/w) mannitol + 1.0 + 1.6 -0 .5
10% (w/w) mannitol + 2.2 + 2.5 + 0.7
0.01% (w/w) 
Poloxamer 188
0 0 0
100 mM n- 
methylacetamide
- 1.0 0 -2 .0
3% (w/w) L-histidine + 0.1 + 0.2 - 1.1
3% (w/w) L- 
histidine, 0.01% 
(w/w) Poloxamer 
188
+ 0.1 + 0.2 - 1.0
100 mM methyl-(3- 
cyclodextrin
-4 .8 -3 .7 -6 .0
100 mM 
hydroxypropyl-p- 
cyclodextrin
-2 .3 -3 .0 -2 .1
3% (w/w) L- 
histidine, 100 mM 
methyl-p- 
cyclodextrin
-4 .9 -3 .6 -5 .4
Table 5.2: Short-term effects of a range of additives on the Tm of the main endothermic 
transition of the three mAbs; Campath-IH (pH 6 CBS), 4162W94 (pH6 CBS) and 1209W95 
(pH 8 TBS) with respect to control samples with no additives with Tm values of 78.2 °C, 77.1 
°C, and 61.3 °C respectively. All data were recorded at a nominal scan rate of 60 °C/hr. 
Buffer baselines have been subtracted and all data concentration normalized.
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ADDITIVE ATm (°C) 
Campath-IH, pH 6
ATm (°C) 
1209W95, pH 8
5% (w/w) mannitol + 1.0 + 1.3
10% (w/w) mannitol + 1.8 + 2.3
0.01% (w/w) 
Poloxamer 188
0 + 0.2
100 mM n- 
methylacetamide
- 1.0 -0 .4
3% (w/w) L-histidine + 0.1 + 0.3
3% (w/w) L- 
histidine, 0.01% 
(w/w) Poloxamer 
188
+ 0.1 + 0.3
100 mM methyl-p- 
cyclodextrin
-4 .8 -3 .8
100 mM 
hydroxypropyl-P- 
cyclodextrin
-2.1 - 1.5
3% (w/w) L- 
histidine, 100 mM 
methyl-P- 
cyclodextrin
-4 .9 -3 .8
Table 5.3: Long-term effects (two years at 4 °C) of a range of additives on the Tm of the 
main endothermic transition of Campath-IH (pH 6 CBS) and 1209W95 (pH 8 TBS) with 
respect to long-term stored control samples with Tm values of 78.6 °C and 62.6 °C for 
Campath-IH and 1209W95 respectively. All data were recorded at a nominal scan rate of 60 
°C/hr. Buffer baselines have been subtracted and all data concentration normalized.
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ADDITIVE Ks» (M'1) 
Campath-IH, 
long-term
Ks.OM-')
1209W95,
long-term
CONTROL 0.705 ±0.025 3.23 ±0.07
5% (w/w) mannitol 0.715 ±0.025 2.64 ±0.08
10% (w/w) mannitol 0.575 +0.105 2.92 ±0.24
0.01% (w/w) 
Poloxamer 188
0.455 ±0.105 3.00 ±0.1
100 mM n- 
methylacetamide
0.480 ±0.060 3.34 ±0.06
3% (w/w) L-histidine 0.555 ±0.125 2.92 ±0.09
3% (w/w) L-histidine, 
0.01% (w/w) 
Poloxamer 188
0.560 ±0.020 3.00 ±0.27
100 mM methyl-p- 
cyclodextrin
0.720 ±0.025 3.13 ±0.01
100 mM 
hydroxypropyl-P- 
cyclodextrin
0.520 ±0.020 2.66 ±0.22
3% (w/w) L-histidine, 
100 mM methyl-P- 
cyclodextrin
0.650 ±0.022 2.78 ±0.22
Table 5.4: Table showing the effect of formulation additives on the accessibility of
tryptophan residues within the mAbs Campath-IH (pH 6) and 1209W95 (pH 8) after 2 years 
at 4 °C, as measured by fluorescence quenching. Ksv represents the Stem-Volmer constant; 
the larger the value of this constant, the more accessible the tryptophan residues to quencher. 
Control samples consisted of Campath-IH (pH 6 CBS) and 1209W95 (pH 8 TBS) stored 
under identical conditions. The quencher used was a 2.5 M solution of succinimide.
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ADDITIVE Campath-IH
A-max (nm), I (cps)
1209W95 
A™* (nm), I (cps)
CONTROL 517, 9.49xl04 515, 1.11x10s
5% (w/w) mannitol 517, 1.13xl05 512, 1.18xl05
10% (w/w) mannitol 517, 1.08xl05 510, 1.25x10s
0.01% (w/w) 
Poloxamer 188
494, 1.49xl05 504, 1.44xl05
100 mM n- 
methylacetamide
442, 3 .61xl05 509, 1.33xl05
3% (w/w) L-histidine 515, 1.18xl05 513, 1.28xl05
3% (w/w) L-histidine, 
0.01% (w/w) 
Poloxamer 188
513, 1.36xl05 507, 1.60xl05
100 mM methyl-p- 
cyclodextrin
462, 1.51xl07 472, 1.39xl07
100 mM 
hydroxypropy 1- p- 
cyclodextrin
471, 1.47xl07 471, 1.47xl07
3% (w/w) L-histidine, 
100 mM methyl-P- 
cyclodextrin
463, 1.50xl07 471, 1.37xl07
Table 5.5: Table showing the effects of additives on the fluorescence of ANS in the presence 
of Campath-IH (pH 6 CBS) and 1209W95 (pH 8 TBS). Both the wavelength of the emission 
maximum (A™*) and the fluorescence intensity at that wavelength (I/counts per second) are 
tabulated. Control samples were Campath-IH in pH 6 CBS and 1209W95 in pH 8 TBS 
stored under identical conditions. All experiments were performed at 25 °C at a protein 
concentration of 0.2 pM, ANS concentration of 20 (iM and an excitation wavelength of 390 
nm was used throughout.
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Concentration of 
HPCD (%  (w/w))
Tml  (°C) Tm2(°C ) Tm3 (°C)
0 69.4 78.2 (-)
15 69.4 76.1 (-)
20 69.4 75.3 (-)
30 69.4 74.2 81.9
40 69.4 73.5 82.5
Table 5.7: The effect of HPCD concentration on the Tm values of Campath-IH (0.013 mM, 
pH 6) as determined by DSC. (-) indicates the absence of a third endotherm at these HPCD 
concentrations. All scans were performed at a scanning rate of 60 °C/hr.
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Figure 5.1: Results of succinimide quenching of Campath-IH (pH 6 CBS) plotted as a 
Stem-Volmer plot. Main graph shows quenching of Campath-IH in comparison to fully 
exposed tryptophan. Ksv values are 1.1 ±0.1 and 13.9 ±0.3 M 1 for Campath-IH and fully 
exposed tryptophan respectively. Inset shows detail of Campath-IH data showing slight 
negative deviation. All data recorded at 25 °C and using excitation wavelength of 295 nm.
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Figure 5.2a: Results o f acrylamide quenching of Campath-IH (pH 6 CBS) plotted as a Stem- 
Volmer plot. Graph shows quenching of Campath-IH in comparison to fully exposed 
tryptophan and illustrates positive deviation of data obtained on quenching fiilly exposed 
tryptophan due to static quenching. All data recorded at 25 °C and using excitation 
wavelength of 295 nm.
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Figure 5.2b: Results of acrylamide quenching of Campath-IH (pH 6 CBS) plotted as a 
modified Stem-Volmer plot. Graph shows quenching of Campath-IH in comparison to fully 
exposed tryptophan. Ksv values are -0.6 ±0.1 and 7.5 ±0.2 M'1 for Campath-IH and fully 
exposed tryptophan respectively. All data recorded at 25 °C and using excitation wavelength 
of 295 nm.
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Figure 5.3: Reducing 15% SDS PAGE of equimolar amounts o f 2), 3) Campath-IH (pH 
7.2 PBS) and 4), 5) Campath-IH (pH 3 CBS). Lanes 1) and 6) show molecular weight 
standards.
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Figure 5.4: Raw DSC data showing the effects of 15, 20, 30 and 40% (w/w) HPCD on 
Campath-IH (0.013 mM, pH 6 CBS). Scans were performed at a nominal scan rate of 60 
°C/hr, are y-offset for clarity and are shown after baseline subtraction. Graph shows 30 and 
40% (w/w) HPCD results in a third endotherm and also prevents exothermic aggregation and 
posttransition baseline noise.
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Figure 5.5: Effect of scan rate on the DSC trace of Campath-IH (0.018 mM, pH 6 CBS, 
40% (w/w) HPCD). Graph shows raw data produced on scanning at six different scan rates: 
(a) 10.7, (b) 17.9, (c) 26.8, (d) 39.8, (e) 51.0 and (f) 72.3 °C/hr and illustrates the scan rate 
dependence of the Tm values of both transitions. Buffer baselines have been subtracted and 
scans are y-offset for clarity.
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Figure 5.6: Raw DSC data showing the effects of 15, 20, 30 and 40% (w/w) HPCD on 
4162W94 (0.013 mM, pH 6 CBS). Scans were performed at a nominal scan rate of 60 °C/hr, 
are y-offset for clarity and are shown after baseline subtraction. Graph shows 40% (w/w) 
HPCD results in a third endotherm and also prevents exothermic aggregation and 
posttransition baseline noise.
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Figure 5.7a: Raw DSC data showing the effect of 0.5 and 1 % (w/w) DEAE-dextran on the 
thermal unfolding of Campath-IH (0.0161 mM, pH6 CBS). Scans were performed at a 
nominal scan rate of 60 °C/hr, buffer baselines have been subtracted and data are y-offset for 
clarity.
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Figure 5.7b: Raw DSC data showing the effect of combinations of DEAE-dextran and 
lacititol on the thermal unfolding of Campath-IH (0.0196 mM, pH6 CBS). All quantities are 
% (w/w). Scans were performed at a nominal scan rate of 60 °C/hr, buffer baselines have 
been subtracted and data are y-offset for clarity.
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INDUCTION AND KINETICS OF mAb AGGREGATION
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6.1 Introduction
During the formulation development of Campath-IH by Glaxo Wellcome, the 
formation of ‘discrete macroscopic particles’ in the protein solution was observed (Wellcome 
Company Document No: GA/LJ/027, private communication). These particles were of 
protein origin and it was suspected that they were either aggregates formed by denaturation of 
the mAb at the liquid/air interface, or some form of aggregates of Ig proteolysis fragments. 
Insoluble protein deposits are known to form from Ig fragments of proteolysis under acidic 
conditions (Glenner et al., 1971). Irrespective of the source, these fragments caused concern 
with respect to the long-term solution stability of the drug.
When considering the apparent spontaneous formation of macroscopic structures 
from solutions of Campath-IH, one can draw analogies with the formation of amyloid 
deposits in the various amyloidigenic disease states e.g. Alzheimer’s and scrapie. Recent 
reports in the literature have shown that protein molecules in a particular conformational 
state, which is not necessarily the native one, are able to stimulate or catalyse a similar 
conformational transition in vitro (Paushkin et al., 1997). These and similar experiments with 
prion peptides (Kaneko et al., 1997) also indicate a possible mechanism for this 
conformational autocatalysis. Expansion of this theory allows for the possibility that other 
proteins including Campath-IH may be induced to aggregate by the addition of ‘catalytic’ 
amounts of preformed aggregate by a classic nucleation/growth mechanism (Harper and 
Lansbury, 1997) whereby the rate-limiting step is the initial formation of a nucleus or cluster 
of aggregated protein upon which subsequent growth may proceed more readily by accretion. 
If this is tme, the rate of aggregation would increase rapidly (and non-linearly) with 
concentration of the unfolded protein, and, could be ‘seeded’ by the addition of preformed 
aggregates.
Despite sterile filtering of solutions of Campath-IH, denatured protein can still form 
at liquid/glass and liquid/air interfaces (MacRitchie, 1978). If these denatured states 
aggregate (it has been shown in Chapter 3 that with Campath-IH, at physiological pH, 
thermal denaturation coincides with thermal aggregation) they may catalyse the formation of 
further aggregate. Attempts to test this theory using DSC in a similar fashion to those 
experiments described in Chapter 4 wherein kinetic parameters were derived from DSC 
thermograms in accordance with the methods described by Sanchez-Ruiz et al., (1988a) were
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carried out as, in the case of autocatalysis, changes in the activation energies and the rate 
constants for the unfolding process on adding preformed aggregate would be expected and 
even if the preformed aggregate was not acting as a true catalyst but was still affecting the 
rate of formation of subsequent aggregates, a change in the rate constant would be expected. 
Other methods of measuring the rate of aggregation of Campath-IH described in this chapter 
involve the UV/visible spectrophotometry to measure protein concentration within solutions 
and to measure the turbidity of protein solutions both in the presence and absence of 
preformed aggregate.
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6.2 Results
6.2.1 Turbidity Experiments
Experiments involving the measurement of the protein concentrations of the 
supernatants from samples of Campath-IH seeded with preformed aggregate and then 
incubated at elevated temperatures were carried out over extended periods of time (typically 
nine days). Results from these experiments were inconsistent and irreproducible, probably 
due to variations in incubation temperatures caused by the removal of samples from the 
waterbath for UV analysis and therefore the results are not presented in this thesis. 
Alternatively, this may reflect the real unpredictable nature of nucleation/aggregation 
processes, especially in the absence of deliberate seeding. Results gained from monitoring the 
turbidity of Campath-IH solutions seeded with preformed aggregate were far more 
reproducible as these experiments were carried out over the course of some hours rather than 
days.
Figure 6.1a presents the data from an experiment studying the effect of the addition of 
0.5 and 1% (v/v) of a dispersed solution of thermally aggregated Campath-IH (0.009 mM, 
pH 6 CBS), formed by heating to 85 °C in a waterbath, to samples of Campath-IH (0.009 
mM, pH 6 CBS) incubated at 67 °C, on the turbidity of the samples as measured by the 
absorbance at 320 nm. The turbidity of each sample was recorded at regular time intervals 
and the data plotted as a graph of absorbance at 320 nm against time. The control experiment 
involved measuring the turbidity of a sample of the same solution of Campath-IH incubated 
under the same conditions without any added preformed aggregate. Figure 6.1b presents the 
data obtained by recording the absorbance of the same samples at 400 nm. The most obvious 
feature of both figure 6.1a and 6.1b is the long lag phase from 0 minutes to approximately 
175 minutes during which time there is apparently no change in the turbidity of the solutions 
as measured by absorbance at either 320 or 400 nm. This feature is indicative of a 
nucleation/growth process as, after the lag phase, there is a steep growth period (Harper and 
Lansbury, 1997). It is clear that the addition of 0.5 or 1% (v/v) of preformed aggregate does 
not affect the rate of aggregation. These results are reproducible and repeat experiments at 
other temperatures between 65 and 75 °C consistently show that these low concentrations of 
preformed aggregate have no effect on the overall rate of thermal aggregation.
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The effects of adding higher concentrations of preformed aggregate were studied 
using the same experimental protocol. Figures 6.2a and 6.2b show the results from 
experiments monitoring the effect of the addition of 5 and 10% (v/v) preformed aggregate 
solution on the solution turbidity as measured by solution absorbance at 320 and 400 nm 
respectively. Again the lag/growth phase pattern is the most obvious feature of the graphs but 
there is no apparent increase in the aggregation rate on addition of preformed aggregate 
consistent with a catalytic mechanism, in fact, there seems to be a slight reduction on 
aggregation rate on addition of 10% (v/v) solution of preformed aggregate.
The incubation temperature is important for the experiments described above and a 
range of temperatures were investigated. At 73, 74 and 75 °C, aggregation of all samples 
occurred within two hours and therefore not enough absorbance measurements were recorded 
to draw valid conclusions. At temperatures from 65-72 °C, the data were consistent with 
those obtained at 67 °C.
To gain a clearer insight into the effect the addition of preformed aggregate was 
having, experiments were attempted in which preformed aggregate was added, not at the 
beginning of the experiment but during the lag phase. The average duration of the lag phase 
was approximately 175 minutes so experiments were carried out in which small quantities 
(5.0, 10.0% (v/v)) of preformed aggregate were added to the samples after 70 minutes. These 
experiments were repeated four times and the results were inconsistent and irreproducible and 
therefore no data are presented. Despite the inconsistency of the data produced in these 
experiments, a clear lag phase was always observed when the data were plotted.
6.2.2 Effect of Preformed Aggregate on the Kinetics of Thermal Unfolding
Using the method developed by Sanchez-Ruiz et al., (1988a), as described in section 
2.2.3, equations 2.16 and 2.18 were used to calculate the activation energy for the main 
thermal unfolding transition of Campath-IH (0.018 mM, pH 4 ABS) in the presence and 
absence of 1.6% (v/v) solution of dispersed preformed Campath-IH aggregate (0.018 mM, 
pH 4 ABS). Equations 2.15 and 2.17 were not used for these calculations as they require 
data collected at a range of scan rates to produce valid activation energies (see section 2.2.3). 
The DSC scans were performed at 10 °C/hr, the slowest rate that the machine can perform in
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the hope that it would give any nucleation reaction time to proceed and also, under these pH 
conditions, distortion of the DSC thermograms by gross aggregation of the sample does not 
occur. Only a small volume of preformed aggregate was added for two reasons: firstly if 
autocatalysis is occurring then only a catalytic amount of preformed aggregate would be 
needed to ‘seed’ the reaction and secondly, the presence of large amounts of insoluble 
aggregates in the DSC cell can lead to noisy posttransition baselines as a consequence of 
erratic convection effects of these aggregates. The results are presented in table 6.1. The 
calculated activation energies are 441.0 ±10% and 434.1 ±9% kJ m ol1 in the absence and 
presence of preformed aggregate, respectively. These values and the value of 439 kJ m ol1 
presented in table 4.7 (average EA for Campath-IH (pH 4), 2nd transition as calculated using 
equations 2.15-2.18) reveal that there is no apparent change in EA when catalytic amounts of 
preformed aggregate are present. The reduction of activation energy is not a criterion for 
autocatalysis but what is necessary for this process is an increase in the rate of aggregation in 
the presence of preformed aggregate.
Experiments carried out on solutions of Campath-IH (pH 5) in both the presence and 
absence of a range of concentrations of preformed aggregate (0.6, 1.0. 1.4, and 2.0% (v/v)) 
allowed the calculation of rate constants using equation 2.15. Again data was collected at a 
scan rate of 10 °C/hr to maximise conditions for any nucleation reaction which may take 
place. Figure 6.3 shows the data plotted as a graph of rate constant, k, against temperature 
for each of the preformed aggregate concentrations analysed. The control sample was an 
identical solution of Campath-IH without any added preformed aggregate. Figure 6.3 clearly 
shows the linear relationship between the rate constant, k, and temperature, T, and it is also 
clear from the graph that the addition of preformed aggregate has no significant effect on the 
rate of thermal denaturation.
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6.3 Discussion
The experiments described in this chapter were conceived and executed in the hope 
that the aggregation of Campath-IH would be shown to proceed via a nucleation growth 
mechanism whereby a solution of Campath-IH could be induced to aggregate by the addition 
of a ‘seed’ of preformed aggregate. This seed would allow further aggregation by accretion. 
In fact, all experimental evidence obtained suggests that the addition of preformed aggregate 
has no effect whatsoever on the rate of Campath-IH aggregation. The investigation 
comprised a two-pronged approach: firstly solutions of Campath-IH were incubated with 
varying amounts of preformed aggregate and any change in the turbidity of the solutions 
monitored by UV-visible spectrophotometry, and secondly, the effect of adding preformed 
aggregate on the kinetics of the irreversible thermal denaturation of Campath-IH was studied.
By monitoring the turbidity of seeded and non-seeded Campath-IH solutions, 
aggregation profiles were produced which were representative of a classic nucleation/growth 
process in that the profiles consisted of a lag phase followed by a steep growth curve (Harper 
and Lansbury, 1997). The effect of adding a range of quantities of preformed aggregate and a 
range of incubation temperatures was studied and each experiment resulted in a reproducible 
lag/growth phase curve although there was no significant difference in the curves produced in 
the presence of aggregate when compared to the controls. In the hope that the addition of seed 
during the lag phase would induce a clear growth effect, aggregate was indeed added during 
the lag phase but no significant effect was observed suggesting that either the nucleation 
growth process was unaffected by preformed aggregate or the experimental set up was not 
suitable for studying such a system. The lag phase clearly supports a nucleation/growth 
mechanism- so why does preformed aggregate not act as a seed for the process? One 
explanation could be that the preformed aggregate undergoes some other change after 
formation that prevents it nucleating further aggregation or alternatively aggregate formed by 
thermal unfolding of protein is unsuitable as a seed.
The results of experiments monitoring the effect of preformed aggregate on the values 
of the kinetic parameters of the irreversible thermal denaturation of Campath-IH derived 
using the method developed by Sanchez-Ruiz, et al., (1988a) are more conclusive. The 
results show that the addition of preformed aggregate affects neither the activation energy nor 
the rate constants of thermal denaturation under the conditions studied. If aggregation was
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proceeding via a nucleation/growth mechanism one would expect to observe a significant 
increase in the rate of the aggregation process which would be indicated by an increase in the 
reaction rate.
Chapter 6
mAb (pH) Ea Ea Average EA
/kJ mol'1 /kJ mol'1 /kJ mol'1
Eq. 2.16 Eq. 2.18
Campath-IH (pH 4), 2nd 457 ±9% 425 ±11% 441 ±10%
transition.
Campath-IH (pH 4), 2nd 451 ±10% 417 ±8% 434 ±9%
transition +1.6%  (v/v)
preformed aggregate.
Table 6.1: Activation energies (E a) calculated using equations 2.16 and 2.18 for Campath- 
IH (pH 4) in the presence and absence of 1.6% (v/v) solution of preformed Campath-IH 
aggregate.
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Figure 6.1a: Graph showing the effect on solution turbidity of the addition of 0.5 and 1.0% 
(v/v) Campath-IH aggregate solution (0.009 mM, pH 6 CBS) to samples of Campath-IH 
(0.009 mM, pH 6 CBS) incubated at 67 °C, with time. Solution turbidity is measured as the 
absorbance at 320 nm. Control samples were samples of the same Campath-IH solution 
incubated under identical conditions without any preformed aggregate added.
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Figure 6.1b: Graph showing the effect on solution turbidity of the addition of 0.5 and 1.0% 
(v/v) Campath-IH aggregate solution (0.009 mM, pH 6 CBS) to samples of Campath-IH 
(0.009 mM, pH 6 CBS) incubated at 67 °C, with time. Solution turbidity is measured as the 
absorbance at 400 nm. Control samples were samples of the same Campath-IH solution 
incubated under identical conditions without any preformed aggregate added.
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Figure 6.2a: Graph showing the effect on solution turbidity of the addition of 5.0 and 10.0% 
(v/v) Campath-IH aggregate solution (0.009 mM, pH 6 CBS) to samples of Campath-IH 
(0.009 mM, pH 6 CBS) incubated at 67 °C, with time. Solution turbidity is measured as the 
absorbance at 320 nm. Control samples were samples of the same Campath-IH solution 
incubated under identical conditions without any preformed aggregate added.
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Figure 6.2b: Graph showing the effect on solution turbidity of the addition of 5.0 and 10.0% 
(v/v) Campath-IH aggregate solution (0.009 mM, pH 6 CBS) to samples of Campath-IH 
(0.009 mM, pH 6 CBS) incubated at 67 °C, with time. Solution turbidity is measured as the 
absorbance at 400 nm. Control samples were samples of the same Campath-IH solution 
incubated under identical conditions without any preformed aggregate added.
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Figure 6.3: Graph of rate constants, k, calculated using equation 2.15, plotted against 
temperature, T, for the thermal denaturation of Campath-IH (pH 5 CBS) in the presence of 
0.6, 1.0. 1.4, and 2.0% (v/v) solution of preformed Campath-IH aggregate. The control 
experiment was a sample of Campath-IH (pH 5 CBS) without any preformed aggregate 
added. DSC data were collected at a scan rate of 10 °C/hr.
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CHAPTER 7 
FURTHER OBSERVATIONS
Chapter 7
7.1 Introduction
This chapter contains data relevant to the stability of mAbs which were the result of 
experiments which, due to time constraints, were not taken to their natural conclusion and 
therefore do not justify a unique chapter to themselves. The experiments were designed to 
investigate two broad areas of mAb stability: firstly the effect of low concentrations of 
denaturants such as urea and guanidine hydrochloride (GdmHCl) on their behaviour and 
secondly the usefulness of isothermal calorimetry for studying mAb thermal denaturation. A 
brief introduction to the reasoning behind these areas of study follows.
7.1.1 The Effects of Low Concentrations of Denaturants
Monitoring changes in protein structure with fluorescence spectroscopy and/or CD as 
a function of denaturant concentration is a common method of measuring the folding stability 
of the protein (Wong and Tanford, 1973; Vuilleumier, et al., 1993; Kelly and Price, 1997; 
Freskgard, et al., 1998). This technique can also be applied to investigate the existence of 
folding intermediates if the unfolding curves as monitored by fluorescence spectroscopy and 
CD are noncoincident (Matthews and Crisanti, 1981; Van Mierlo et al., 1998). Contained in 
this chapter are the results of such unfolding experiments for Campath-IH, 4162W94 and 
1209W95 and some preliminary conclusions are drawn.
7.1.2 Isothermal Calorimetry
While DSC measures the heat uptake of a sample over a specified temperature range, 
isothermal calorimetry measures the heat uptake over a specified time period at a constant 
temperature and in the past has been used mainly to measure the kinetics of the decomposition 
of traditional organic drug molecules (Hansen, et al., 1989; Angberg et al., 1993). DSC is by 
far the most common method of measuring thermal denaturation of proteins, but, as discussed 
in chapter 4, the thermodynamic analysis of DSC curves relies on the assumption that 
equilibrium exists throughout the temperature-induced unfolding process (Privalov and 
Khechinashvili, 1974) and when used to study irreversible processes DSC data cannot be 
analysed in terms of equilibrium thermodynamics; only kinetic data can be obtained (Lepock, 
et al., 1992; Sanchez-Ruiz, 1992). Accurate kinetic data can be obtained from DSC traces if 
the DSC signal is split up into the separate contributions of the denaturation and aggregation
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processes (Sandu and Singh, 1990) but most DSC instruments do not have the ability to scan 
at slow enough rates to achieve this separation and frequently only one peak is observed with 
very little fine structure. Also, at temperatures below the Tm, the processes involved in 
protein denaturation and aggregation will take place on a much larger timescale than a DSC 
experiment making the calculation of accurate kinetic parameters difficult.
True isothermal calorimetry can be helpful in these situations as, since the heat 
uptake of a sample is measured at a fixed temperature, one fewer variable is introduced into 
any subsequent analysis (Waters and Paddy, 1988). Because of the need for extremely 
sensitive instrumentation, especially when the sample being studied is a protein, very little 
published work is available, however Hoffmann et al., (1997) have studied the denaturation 
and aggregation of (3-lactoglobulin using isothermal calorimetry utilising a denaturation and 
aggregation model derived by Roefs and de Kruif (1994). In an attempt to use this method of 
calorimetry to gain a better understanding of the processes involved in mAb denaturation and 
aggregation, preliminary experiments with Campath-IH were carried out and the results 
presented in this chapter.
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7.2 Results
7.2.1 Unfolding with Denaturants
All three mAbs: Campath-IH (pH 6 citrate), 4162W94 (pH 6 citrate) and 1209W95 
(pH 8 Tris) were unfolded using GdmHCl from 0-6 M and monitored by CD (ellipticity at 
210 nm) and fluorescence spectroscopy (emission at 360 nm). The CD results are shown in 
figure 7.1 plotted as the percentage change in ellipticity at 210 nm versus GdmHCl 
concentration. The midpoint of the unfolding curves are 2.5, 3.0 and 1.9 M GdmHCl for 
Campath-IH, 4162W94 and 1209W95 respectively. It is interesting that 1209W95 which is 
the least thermally stable of the three mAbs is also the least chemically stable in addition to 
having the most accessible tryptophan residues as shown by succinimide quenching. Figure
7.2 presents the data from the GdmHCl unfolding as monitored by fluorescence spectroscopy. 
The data are plotted as fluorescence intensity at 360 nm versus GdmHCl concentration and 
the midpoints of these unfolding curves are 3.5, 2.8 and 2.6 M GdmHCl for Campath-IH, 
4162W94 and 1209W95 respectively. 1209W95 is unique in this respect as it does not 
follow a classical unfolding curve in that significant structural changes occur even at the 
lowest concentrations of GdmHCl. It is clear from the midpoints of the unfolding curves that 
all three mAbs unfolding curves as determined from CD are noncoincident with those obtained 
by fluorescence measurements which suggests the chemical unfolding is a multistate process 
which is consistent with the conclusions drawn from DSC experiments concerning the thermal 
unfolding as discussed in chapter 4.
During these experiments it was noticed that the fluorescence intensity (at 360 nm) of 
Campath-IH significantly decreased on going from 0-2.5 M GdmHCl due to a blue shift of 
the emission spectrum which is indicative of the tryptophan residues within the molecule 
becoming less exposed to the solvent. This would seem to suggest that the molecule is 
becoming more tightly packed and rigid- the opposite of what one expects during chemical 
denaturation. This apparent reduction in protein mobility has been reported within crystalline 
proteins with bound denaturant at low (<1 M) concentrations where the decrease in mobility is 
detected as a decrease in the temperature factor (B-factor) of the protein crystals (Dunbar, et 
al., 1997). To probe the accessibility of the tryptophan residues at these low GdmHCl 
concentrations, succinimide quenching experiments were carried out and results, presented as 
Stem-Volmer plots, are given in figure 7.3. Ksv for Campath-IH in the presence of 0.5 M
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GdmHCl is 0.98 ±0.03 M'1 compared to 1.20 ±0.08 M'1 at 0 M GdmHCl. These KsV values 
support the hypothesis that the molecule does indeed become more rigid and tightly packed in 
the presence of low GdmHCl concentrations and the implications of this finding will be 
discussed later. DSC experiments were carried out to study whether 0.5 M GdmHCl affected 
the Tm of Campath-IH (pH 6) and a reduction to 70.3 °C from 78.2 °C was observed for the 
main transition and the sample had aggregated when removed from the cell.
DSC experiments were carried out to investigate whether low concentrations of urea, 
a weaker denaturant than GdmHCl, had any effect on the thermal unfolding of Campath-IH. 
Some of the data produced is presented in figure 7.4. This figure presents the raw DSC data 
obtained on scanning Campath-IH (0.0201 mM, pH 6 CBS) and Campath-IH (0.0201 mM, 
pH 6 CBS, 0.5 M urea). The baseline scans have been subtracted and scans are y-offset for 
clarity. The presence of the urea increases the Tm of the main unfolding transition by 11 °C 
and also the AHcai for the transition is also greatly increased (data could not be fitted using 
Origin software and therefore values for AH^ are not reported). Successive scanning in the 
presence of 0.5 M reveals a degree of reversibility and sees both the Tm and AH^ decrease. 
Gross aggregation of the sample is also prevented. To probe whether 0.5 M urea disrupts the 
structure of Campath-IH, the urea unfolding curve was recorded using CD and the results, 
plotted as the percentage change in ellipticity at 210 nm as a function of urea concentration, 
are presented in figure 7.5. The urea unfolding curve has its midpoint at 6.8 M urea. From 
figure 7.5 it is clear that 0.5 M urea has no apparent effect on the structure of the antibody.
7.2.1 Isothermal Calorimetry
The results of preliminary isothermal calorimetry experiments using Campath-IH are 
presented in this chapter. Once temperature and concentration trials were performed data 
were collected revealing the high quality of data that can be obtained and both the temperature 
and concentration dependence of the traces. Figure 7.6 presents the raw data from isothermal 
measurements of Campath-IH (0.1054 mM, pH 6 CBS) performed at 67.5, 68.5, 69.5, 70.5 
°C. This temperature range was chosen as it is below the Tm of the main transition as defined 
by DSC, and therefore the sample would not aggregate immediately, and data could be 
collected. It is also a temperature range where unfolding reaction would be occurring on a 
reasonable timescale for data collection. The data reveal obvious temperature dependence of
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the scans. Figure 7.7 comprises the raw isothermal data collected from scans carried out at 
70.5 °C on Campath-IH (pH 6 CBS) at 0.023, 0.412, 0.054, 0.063 and 0.1054 mM 
concentrations. The concentration dependence of the traces is evident. These data were then 
normalized and the data presented in figure 7.8 and again the concentration dependence of the 
traces is evident. Figures 7.6-7.8 show how, when held at constant temperature close to the 
unfolding transitions, heat uptake is observed. This heat uptake gradually decays over a 
period of time, presumably as all the protein in the cell irreversibly unfolds.
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7.3 Discussion
By monitoring the unfolding behaviour of Campath-IH, 4162W94 and 1209W95 in 
increasing concentrations of GdmHCl, using both CD and intrinsic tryptophan fluorescence 
spectroscopy, we can draw two conclusions. Firstly, both techniques reveal that the least 
chemically stable antibody is 1209W95 which is also the least thermally stable (Tm =61.3 
±0.1 °C at pH 8) and also the antibody with the highest Stem-Volmer constant (Ksv =3.9 ±0.2 
M'1). This is probably due to the fact that 1209W95 is an antibody-TMT conjugate and the 
TMT moiety may cause a disruption in the antibody structure which makes the molecule less 
tightly packed than either Campath-IH or 4162W94 and therefore the thermal stability is 
decreased and also the tryptophan residues within the molecule will be more accessible to 
solvent and hence the large KsV value. The second conclusion is drawn from the fact that the 
Campath-IH and 1209W95 unfolding curves, as monitored by CD and by fluorescence 
spectroscopy are noncoincident, and therefore the unfolding of these two mAbs involves 
folding intermediates (Matthews and Crisanti, 1981; Van Mierlo, et al., 1998). This is in 
agreement with conclusions from chapter 4 which suggested that the thermal unfolding of both 
Campath-IH and 1209W95 involved at least one significantly populated intermediate phase 
as the ratio of the calorimetric and van’t Hoff enthalpies of the unfolding transitions, as 
determined by DSC (AHVH/AHca]), are less than unity (Sturtevant, 1987).
The GdmHCl unfolding curve as monitored by fluorescence spectroscopy also 
revealed that at low concentrations of denaturant ([GdmHCl]<2.5 M) the Campath-IH 
molecule is more tightly packed and rigid than at zero denaturant concentration. This was 
revealed by the fact that the emission spectrum is blue shifted at these low GdmHCl 
concentrations. Further proof of this phenomenon was obtained by succinimide quenching 
techniques which resulted in a Ksv of 0.98 ±0.03 M 1 for Campath-IH (pH 6, 0.5 M GdmHCl) 
compared to a Ksv of 1.20 ±0.08 M'1 in the absence of GdmHCl indicating the tryptophan 
resides are less accessible when the molecule is exposed to 0.5 M GdmHCl. This finding is in 
agreement with studies on the effects of GdmHCl on the crystal structure of ribonuclease A 
by Dunbar et al., (1997). However, this increase in rigidity and mobility is not mirrored by 
an increase in the Tm as measured by DSC.
0.5 M urea has an unusual effect on the DSC thermogram of Campath-IH (pH 6) as 
shown in figure7.4. The urea increases the reversibility of unfolding, causes an apparent
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increase in the AH^, and also causes a large decrease in the Tm. The urea unfolding curve 
obtained by CD suggests that 0.5 M urea exerts no significant structural effects and time 
constraints prevented futher investigation which may have lead to a conclusion.
Preliminary isothermal calorimetry results with Campath-IH show the high 
temperature and concentration dependence of the traces. Our results show that isothermal 
calorimetry is a valid technique to use to investigate the thermal denaturation of mAbs and, 
since it offers the advantage of greater simplicity of interpretation of data over DSC it is 
possible it may lead to greater confidence in the values of the derived kinetic parameters. The 
main disadvantages though are the necessity for protein solutions of high concentration and 
also the time involved in carrying out a single experiment and for some workers these 
disadvantages may prove inhibitory.
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Figure 7.1: GdmHCl unfolding curves for Campath-IH (pH 6), 4162W94 (pH 6) and 
1209W95 (pH 8) as monitored by CD. Graph is plotted as the percentage change in 
ellipticity at 210 nm versus GdmHCl concentration and the midpoints of the curves are 2.5, 
3.0, and 1.9 M GdmHCl for Campath-IH, 4162W94 and 1209W95 respectively.
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Figure 7.2: GdmHCl unfolding curves for Campath-IH (pH 6), 4162W94 (pH 6) and 
1209W95 (pH 8) as monitored by fluorescence spectroscopy. Graph is plotted as the 
percentage change in fluorescence intensity at 360 nm versus GdmHCl concentration and the 
midpoints of the curves are 3.5, 2.8, and 2.6 M GdmHCl for Campath-IH, 4162W94 and 
1209W95 respectively.
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Figure 7.3: Results of succinimide quenching of Campath-IH (pH 6 CBS) and Campath-IH 
(pH 6 CBS/0.5 M GdmHCl) plotted as a Stem-Volmer plot. Ksv values are 1.20 ±0.08 and 
0.98 ±0.03 M'1 in the absence and presence of 0.5 M GdmHCl respectively. All data were 
recorded at 25 °C using an excitation wavelength of 295 nm.
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Figure 7.4: Raw DSC data showing effect of 0.5 M urea on the Tm of the main endothermic 
transition of Campath-IH (pH 6 CBS). Data from four successive scans are shown to 
illustrate the partial calorimetric reversibility of the transition. A scan performed in the 
absence of urea is shown on the same scale for comparison.
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Figure 7.5: Urea unfolding curve for Campath-IH (pH 6) as monitored by CD. Graph is 
plotted as the percentage change in ellipticity at 210 nm versus urea concentration and the 
midpoint of the curve is 6.8 M urea.
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Figure 7.6: Raw isothermal calorimetry data for Campath-IH (0.1054 mM, pH 6 CBS) 
showing temperature dependence of scans. Four separate traces at 67.5, 68.5, 69.5 and 70.5 
°C are shown.
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Figure 7.7: Raw isothermal calorimetry data for Campath-IH (pH 6 CBS) at a range of 
concentrations (0.023, 0.0412, 0.054, 0.063, and 0.1054 mM) showing concentration 
dependence of data. Data for all traces were collected at 70.5 °C.
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Figure 7.8: Normalized isothermal calorimetry data for Campath-IH (pH 6 CBS) at a range 
of concentrations (0.023, 0.0412, 0.054, 0.063, and 0.1054 mM) illustrating the 
concentration dependence of the trace profiles. All data were collected at 70.5 °C.
152
Chapter 8
CHAPTER 8 
GENERAL CONCLUSIONS
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This thesis has: investigated the stability of mAbs in terms of their thermal 
characteristics in solution using DSC, CD and fluorescence spectroscopy; compared the 
effects of pH and additives on the reversibility of thermal denaturation and aggregation; 
studied the dynamic accessibility of protein groups using fluorescence quenching techniques; 
related calorimetric and kinetic parameters to the long-term storage properties of these 
proteins, and applied these techniques to aged samples to examine the long-term effects of 
additives. A summary of the findings is given below:
• The three mAbs Campath-IH, 4162W94 and 1209W95 thermally unfold in two main 
steps, both endothermic. The first step involves a small change in tertiary structure, 
probably some minor domain rearrangement, which is reversible under certain conditions. 
The second step involves major irreversible changes in both tertiary and secondary 
structure which is immediately followed by loss of all structure.
• Analysis of the irreversible thermal unfolding of the mAbs allows the calculation of the 
activation energies and rate constants for the unfolding reaction. These rate constants can 
then be extrapolated back to physiological conditions and the shelf-life of the protein under 
these conditions calculated. This half-life is relevant when thermal unfolding is the only 
mechanism of protein degradation at work.
• The thermal stability of the mAbs can be significantly increased by the addition of 
mannitol. The cyclodextrins, methyl-P- and hydroxypropyl-P-cyclodextrin both reduce the 
thermal stability and activation energy required to thermally unfold Campath-IH by 
binding to residues on the unfolded form of the protein and shifting the equilibrium in 
favour of this form. The cyclodextrins also have the ability, at high concentrations, to 
prevent the gross thermal aggregation of the mAbs, probably by masking hydrophobic 
patches on the unfolded protein.
• The addition of preformed aggregate has no significant effect on either the rate of 
aggregation or the activation energy of unfolding of Campath-IH which suggests if the 
formation of Campath-IH aggregate proceeds via a classic nucleation/growth mechanism, 
then the preformed aggregate used is not suitable as a seed for htis process.
This current research updates previous work on the thermal unfolding of mAbs and 
makes attempts to apply recent work on the kinetic analysis of irreversible protein 
denaturation to mAbs which are very complex model systems. This thesis sets limits on the 
usefulness of deriving kinetic data for the purpose of shelf-life calculation and also presents 
valuable data on the effects of various commonly used and novel formulation additives on the 
unfolding of these proteins. This work shows the complementary nature of DSC, CD and
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fluorescence spectroscopy as tools for studying protein unfolding, and in terms of protein drug 
formulation development, shows how these techniques afford data which cannot be arrived at 
by traditional assays of bioactivity.
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